Development of In Vitro Tissue Engineered Blood Vessel Mimics in Complex Geometries for Coronary Stent Testing by Chavez, Robert Dalton
  
 
DEVELOPMENT OF IN VITRO TISSUE ENGINEERED BLOOD VESSEL MIMICS 
IN COMPLEX GEOMETRIES FOR CORONARY STENT TESTING 
 
 
 
A Thesis Presented to the Faculty of 
California Polytechnic State University, San Luis Obispo 
 
 
 
In Partial Fulfillment of the Requirements for the Degree 
Master of Science in Biomedical Engineering 
 
 
 
By 
Robert Dalton Chavez 
June 2012 
 ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2012 Robert Dalton Chavez 
ALL RIGHTS RESERVED 
 iii 
Committee Membership 
 
Title: Development of In Vitro Tissue Engineered Blood Vessel 
Mimics in Complex Geometries for Coronary Stent Testing 
Author: Robert Dalton Chavez 
Date Submitted: June 7, 2012 
 
Committee Chair: Kristen O’Halloran Cardinal, Ph.D. 
Committee Member: Trevor Ryan Cardinal, Ph.D. 
Committee Member: Lily Hsu Laiho, Ph.D. 
 iv 
Abstract 
 
Development of In Vitro Tissue Engineered Blood Vessel Mimics in Complex 
Geometries for Coronary Stent Testing 
Robert Dalton Chavez 
 
Coronary heart disease is the leading cause of death in the United States and 
occurs when plaque occludes coronary arteries. Coronary stents, which may be used to 
treat coronary occlusions, are small metal tubes that are implanted in coronary arteries to 
restore blood flow. After stent implantation, endothelial cells grow over the stent so that 
blood contacts the endothelial cells instead of the stent surface; this event is known as re-
endothelialization. Re-endothelialization prevents blood from clotting on the stent surface 
and is a good predictor of stent success. Blood vessel mimics (BVMs) are in vitro tissue 
engineered models of human blood vessels that may be used to preclinically test coronary 
stents for re-endothelialization. BVMs have been developed in straight geometries, but 
the FDA has recommended that coronary devices be preclinically tested in complex-
shaped simulated vessels when the complex geometries of coronary arteries may 
negatively affect device performance. Coronary geometries may negatively affect the 
tissue response to coronary stents, therefore BVMs should be developed in complex 
geometries. 
The goal of this thesis research was to fully develop complex-shaped scaffolds 
and bioreactors, to develop complex-shaped BVMs with cells located throughout all 
regions of the BVMs, and to develop a complex-shaped BVM with a confluent region of 
 v 
cells. First, bioreactors that can house complex-shaped scaffolds were designed, 
constructed, and validated. Complex-shaped BVMs were then developed by depositing 
cells throughout the entire inner surface of complex-shaped scaffolds, and the average 
and median cell densities throughout all regions of the BVMs were shown to be 
approximately the same order of magnitude as endothelial cell densities in native blood 
vessels. A stent was then successfully deployed in a complex-shaped BVM. The 
complex-shaped BVM straightened out to conform to the stent, which also occurs in 
native blood vessels. Finally, a confluent region of cells was developed on a complex-
shaped scaffold. Complex-shaped BVMs could eventually be used to preclinically test 
coronary stents, coronary drug-delivery systems, coronary imaging modalities, and other 
intravascular technologies. 
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 1 
1. Introduction 
 
1.1. Overview 
The overall goal of this thesis research was to develop a complex-shaped BVM 
for coronary stent testing. 
New coronary devices are constantly under development for the identification and 
treatment of coronary heart disease (CHD). CHD occurs when plaque occludes coronary 
arteries, which often requires treatment. Before clinical use of coronary devices, the 
devices must be tested. Preclinical testing occurs first and involves in vitro laboratory 
studies and in vivo animal studies. Most in vitro studies do not predict complex biologic 
responses to three-dimensional coronary devices, and in vivo animal studies are 
expensive and time-consuming and may show tissue responses that are quite different 
from human tissue responses. Therefore, tissue engineered blood vessel mimics (BVMs) 
were recently developed as cost-effective in vitro living models of human blood vessels 
that can evaluate a human tissue response to three-dimensional coronary devices. BVMs 
have been developed in only straight geometries, but the FDA has recommended that 
coronary devices be preclinically tested in complex-shaped simulated vessels when the 
complex geometries of coronary arteries may negatively affect coronary device 
performance. Complex geometries of coronary arteries may negatively affect the tissue 
response to coronary stents, therefore BVMs should be developed in complex geometries. 
The rest of this introduction establishes in more detail the reasons that BVMs 
should be developed in complex geometries. Specifically, this introduction will describe 
the reasons that the complex geometries of coronary arteries are prone to plaque 
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formation, the types of coronary devices that have been used to identify and treat CHD, 
the preclinical testing methods that have been used to evaluate coronary devices, the FDA 
recommendations for coronary device testing, the types of synthetic models and animal 
models that have been used for coronary device testing, the need for BVMs, and the 
particular need for BVMs in complex geometries. 
 
1.2. Coronary Heart Disease 
Coronary heart disease (CHD) is the leading cause of death in the United States, 
and an American dies of CHD almost every minute [1]. 17.6 million Americans currently 
live with CHD, and costs associated with CHD totaled $177.1 billion in 2010 [1]. CHD 
occurs when plaque occludes coronary arteries. Coronary arteries are the blood vessels on 
the surface of the heart that deliver oxygen- and nutrient-rich blood to the myocardium, 
which is the cardiac tissue responsible for heart contractions. The occlusion of arteries by 
plaque is known as atherosclerosis, and atherosclerotic coronary arteries restrict blood 
flow to the myocardium, starving the myocardium of essential amounts of oxygen and 
nutrients. This condition impairs the heart’s ability to effectively pump blood throughout 
the body, which causes peripheral tissues to receive insufficient amounts of oxygen and 
nutrients, resulting in death of those peripheral tissues. Restricted coronary blood flow 
also causes shortness of breath, myocardial infarction, and death [2]. Because CHD 
affects such a large population, researchers devote significant attention to developing 
treatments for CHD. 
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1.3. Anatomy of Coronary Arteries 
When developing treatments for CHD, researchers take into account the complex 
geometries of coronary arteries (Figure 1.1). The geometries of coronary arteries are 
considered complex because of bends and bifurcations; a bifurcation is defined as the 
branching of a main vessel into two smaller vessels [3]. The American College of 
Cardiology (ACC) and the American Heart Association (AHA) categorize coronary 
arteries based on the severity of their bends: a “non-angulated” coronary artery bends less 
than 45 degrees, a “moderately angulated” coronary artery bends 45 degrees to 90 
degrees, and an “extremely angulated” coronary artery bends more than 90 degrees [3]. 
Because coronary arteries are located on the surface of a beating heart, they oscillate 
between systolic geometries and diastolic geometries: coronary bends become more 
severe during systole and less severe during diastole [4]. 
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Figure 1.1. Anatomy of human coronary arteries. (A) Left and right coronary arteries 
branch off the aorta from openings known as coronary ostia. The main stem of the left 
coronary artery bifurcates into the anterior interventricular artery and the circumflex 
artery. (B) The right coronary artery gives rise to various branch arteries, including the 
artery supplying the sinus node, the acute marginal artery, the inferior interventricular 
artery, and the artery supplying the atrioventricular node. Anatomic variations in 
coronary arteries between humans do exist but are rare. [5] 
Reprinted from [5] with permission. See Appendix P. 
 
1.4. Blood Flow in Coronary Arteries 
Blood flow through the complex geometries of coronary arteries has different 
characteristics than blood flow through straight arteries. In straight arteries, blood 
velocity is highest in the center of the artery [6]. In bent coronary arteries, blood velocity 
is highest near the outer wall of the bend (Figure 1.2 A) [6], and in the branch vessels 
after a coronary bifurcation, blood velocity is highest near the medial walls (Figure 1.2 B) 
[6]. Also, blood flow characteristics change as the heart beats: blood flows distally 
                            
              
 
                           A 
                            
              
 
                                                     B 
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through the coronary arteries during diastole as depicted in Figure 1.2 [6], but during 
systole, blood momentarily flows proximally, opposite the depiction in Figure 1.2 [7]. 
High pressures during systole cause blood flow to reverse direction in coronary arteries 
[7]. 
 
 
Figure 1.2. Schematics of complex-shaped coronary arteries. Blood flows distally (from 
left to right). The multiple small gray curves in A are velocity profiles. In bent coronary 
arteries, flow velocity is highest near the outer wall of the bend, so velocity curves are 
skewed toward the outer wall (A). Branch vessels after a bifurcation have medial walls as 
identified in B; flow velocity is highest near the medial walls in branch vessels after a 
bifurcation, so velocity curves would be skewed toward the medial walls. [6, 8] 
Figure 1.2 A reprinted from [8] with permission. See Appendix P. 
 
1.5. Shear Stress and Atherosclerosis in Coronary Arteries 
The unique blood flow that occurs in complex-shaped coronary arteries creates 
unique shear stress distributions on the coronary walls. In bent coronary arteries, blood 
flows faster near the outer wall of the bend and slower near the inner wall of the bend; 
these blood flow characteristics create low shear stress on the inner walls of bent 
A B 
  
 
 
Bifurcation 
 
 
 
 
 
                                      Lateral Wall 
 
 
 
 
 
 
 
            Medial Walls 
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coronary arteries [6]. In the branch vessels after a bifurcation, blood flows faster near the 
medial walls and slower near the lateral walls; these blood flow characteristics create low 
shear stress on the lateral walls of branch vessels after a bifurcation [6]. Also, blood flow 
that changes direction as the heart cycles through diastole and systole is called oscillatory 
blood flow and creates oscillatory shear stress on coronary walls [9]. 
Low and oscillatory shear stresses are associated with atherosclerosis [9, 10]. A 
low endothelial shear stress environment is the initiating process of atherosclerosis in an 
atherosclerosis-prone host and typically occurs on the inner walls of curved arteries [9]. 
Oscillatory shear stress is associated with early and continued atherosclerosis and 
typically occurs on the lateral walls of branch vessels after a bifurcation [9, 10]. While 
normal shear stress magnitudes are more than 15 dynes/cm2 [11], low shear stress 
magnitudes are less than 10–12 dynes/cm2 [9]. 
Endothelial cells line the lumen of coronary arteries, and low shear stress as a 
result of the unique blood flow that occurs in complex-shaped coronary arteries directly 
affects endothelial cells [12]. Endothelial cells exposed to low shear stress acquire an 
atherogenic phenotype and encourage formation of early atherosclerotic plaques by 
promoting lipid accumulation [9]. Eventually lipids accumulate in the inner lining of 
arteries—the intima—and form large lipid pools that cause cell necrosis [13]. Fibrous 
tissue then encapsulates the lipids and necrotic cells, and the encapsulation is known as 
an early fibroatheroma, the initial plaque that can develop into more lethal plaques [13]. 
The kind of plaque that will develop from an early fibroatheroma depends on local 
factors (e.g. the magnitude of shear stress on endothelial cells), systemic factors, and 
genetic factors. There are three kinds of plaques that can develop from an early 
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fibroatheroma: quiescent plaques, stenotic plaques, and thin-cap fibroatheromas (TCFAs) 
(Figure 1.3) [9]. Quiescent plaques cause no symptoms in patients, stenotic plaques 
restrict blood flow, and TCFAs may rupture and cause thrombosis [9, 13]. 
 
 
Figure 1.3. Plaque development in bent coronary arteries. The inner wall of bent 
coronary arteries experiences low endothelial shear stress (ESS), causing formation of 
early fibroatheromas. Arteries may then undergo compensatory expansive remodeling 
that causes quiescent plaque formation, constrictive remodeling that causes stenotic 
plaque formation, or excessive expansive remodeling that causes TCFA formation. [9] 
Reprinted from [9] with permission. See Appendix P. 
 
Plaques categorized as stenotic plaques and as TCFAs that ruptured and caused 
thrombosis are alike in that they can eventually occlude coronary arteries, which prevents 
healthy blood flow to the myocardium and leads to CHD. Because approximately 40% of 
early fibroatheromas develop into stenotic plaques and TCFAs [9], and because both 
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plaques can eventually cause coronary occlusion, researchers aiming to identify and treat 
CHD develop devices specifically for identifying and treating coronary occlusions. 
 
1.6. Devices for Identifying and Treating Coronary Heart Disease 
Patients must first receive a diagnosis of CHD before potential treatment for it can 
begin. When diagnosing patients, physicians use various imaging technologies that help 
visualize narrowed coronary arteries and plaque formations. After compromised coronary 
arteries are identified, various treatments may be used to treat coronary occlusions. 
 
1.6.1. Identifying Coronary Heart Disease 
Angiography is the standard imaging technique used to identify obstructed 
coronary arteries [14]. Angiography involves the insertion of a diagnostic catheter into 
the coronary ostia—the openings of the coronary arteries on the aorta—followed by 
injection of a radiopaque dye into the coronary arteries, followed by acquisition of an x-
ray image known as an angiogram (Figure 1.4) [15]. 
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Figure 1.4. Angiogram of coronary arteries. Coronary lumens appear as dark lines, and 
the black arrow points to a site of total occlusion in a left circumflex coronary artery. [16] 
Reprinted from [16] with permission. See Appendix P. 
 
Although angiography is the standard imaging technique used to identify 
obstructed coronary arteries, intravascular ultrasound (IVUS) has the advantage of 
revealing more details about the severity and extent of atherosclerosis [17]. IVUS 
systems generate intravascular images and consist of a catheter, a miniature transducer on 
the catheter, and a console that processes electrical signals and displays the intravascular 
images [17]. To obtain an intravascular image of a coronary artery, an IVUS catheter is 
inserted into the lumen of the coronary artery and pushed through the lumen until the 
catheter tip reaches regions that require assessment. Ultrasound waves are then reflected 
off the walls of the artery, and the reflected waves are converted to electrical signals and 
processed to generate an image. 
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Angiography, IVUS, and other imaging technologies each have advantages when 
used individually to visualize compromised coronary arteries, but researchers are 
currently combining imaging technologies to create hybrid imaging systems. Such hybrid 
systems combine the advantages of individual imaging technologies to generate 
extremely useful information. For example, a system that combines IVUS and near 
infrared spectroscopy (NIRS) allows specific plaque characteristics in coronary arteries to 
be identified, which may allow researchers to study changes in those specific plaque 
characteristics in response to new treatments [17]. Researchers then may be able to better 
understand the exact effects of the new treatments and then adjust the new treatments to 
work more effectively. 
 
1.6.2. Angioplasty 
After a physician identifies blockages in a patient’s coronary arteries, the patient 
typically receives some sort of intervention that treats the blockages and restores blood 
flow through the blockage site. An established treatment for coronary blockages is 
percutaneous transluminal coronary angioplasty (PTCA) [18]. PTCA is a minimally 
invasive procedure that involves compression of plaque against the coronary walls. The 
following steps are carried out during a PTCA procedure in the clinic: injection of local 
anesthesia into the groin area; placement of a needle into the femoral artery; placement of 
a guide wire through the needle into the femoral artery; movement of the guide wire 
proximally through the femoral artery and eventually to the aorta; placement of a 
diagnostic catheter over the guide wire and movement of the diagnostic catheter to the 
aorta; removal of the guide wire; placement of the diagnostic catheter into an ostium on 
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the aorta; injection of contrast media into the coronary arteries; acquisition of an 
angiogram; identification of a treatable blockage in the angiogram; placement of a guide 
wire through the blockage site in the coronary arteries; placement, inflation, deflation, 
and removal of a balloon at the blockage site (Figure 1.5); use of the balloon at other 
blockage sites in the coronary arteries; injection of contrast media and acquisition of an 
angiogram to check for improvements in luminal diameters; and removal of the catheter 
[15]. 
 
 
Figure 1.5. Placement, inflation, deflation, and removal of a balloon during PTCA. A 
guide wire is placed across the blockage site in a coronary artery, then a balloon catheter 
is placed at the blockage site (B). A balloon is inflated (C) to widen the lumen and then 
deflated. The balloon is repeatedly inflated and deflated with increasing amounts of 
pressure during inflation to further widen the lumen and is then removed, leaving behind 
a widened coronary artery (D). [19] 
Reprinted from [19] with permission. See Appendix P. 
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Although PTCA is an established treatment for coronary occlusions, there is a 
notable drawback to PTCA: restenosis [20]. Restenosis is the re-narrowing of a blood 
vessel after treatment. Restenosis after PTCA can occur as a result of early elastic recoil, 
thrombus formation, neointimal formation, and vascular remodeling [21-23]. Early elastic 
recoil occurs when a blood vessel that was widened via PTCA recoils within minutes to 
hours after the procedure [24, 25]. Thrombus formation occurs when blood clots at the 
treatment site [26]; this event is also known as thrombosis. Neointimal formation occurs 
after traumatic balloon injury and involves the migration of proliferating vascular smooth 
muscle cells to the intima to form new tissue [27]. Vascular remodeling occurs when the 
structure of a blood vessel is altered as a result of changes in cell growth, cell death, cell 
migration, and production or degradation of extracellular matrix [28]. To eliminate 
restenosis after PTCA, researchers are currently developing new PTCA technology. 
One technology currently under development is balloons that deliver drugs to the 
walls of coronary arteries to reduce neointimal formation, thereby reducing restenosis. 
When designing such balloons, researchers must choose drugs that best reduce neointimal 
formation. Some new balloons deliver paclitaxel, which inhibits smooth muscle cell 
proliferation and migration [29]. In addition to choosing the best drugs, researchers must 
also choose design features that deliver adequate quantities of drugs, minimize injury to 
the coronary wall, do not limit blood flow through the treated segment of blood vessel, 
and administer drugs for sufficient time to cause a therapeutic effect [18]. An example of 
a drug-delivering balloon is found on the GENIETM balloon catheter: the balloon has 
proximal and distal occlusive segments to restrict drug delivery to the space between the 
occlusive segments, and liquid paclitaxel jets out of the balloon onto the coronary walls 
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[18]. Another example of a drug-delivering balloon is found on the Sequent® Please 
balloon catheter: the balloon is homogenously coated with paclitaxel that is embedded in 
contrast medium; when the balloon is inflated, the contrast medium releases the 
paclitaxel into the surrounding coronary artery [18]. More research is being conducted to 
further identify the best features for drug-delivering balloons that treat restenosis. 
 
1.6.3. Stents 
Another technology for treating coronary occlusions is stents [30]. Stents are 
latticed tubes that can be crimped onto catheters, placed into the body in a minimally 
invasive way, and then expanded once inside an occluded region of a blood vessel to prop 
open the occluded region. Most commercially available coronary stent systems feature 
balloon-expandable stents [21], but stents are also made in self-expanding versions. 
Balloon-expandable stents can be deployed either after PTCA or simply without PTCA, 
whereas self-expanding stents are designed for deployment after PTCA [21, 31]. The 
following steps may be carried out during a stenting procedure in the clinic: the PTCA 
procedure described previously; placement of a balloon catheter with a crimped stent into 
the blockage site; deployment of the stent at the blockage site (Figure 1.6); deployment of 
stents at other blockage sites throughout the coronary arteries; and injection of contrast 
media and acquisition of an angiogram to check for improvements in luminal diameters 
[15]. Stenting is currently the principal method of percutaneous coronary 
revascularization for patients with CHD [32]. 
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Figure 1.6. Deployment of a balloon-expandable stent in a coronary artery. A balloon 
catheter with a closed stent is inserted into the blockage site (B), the balloon is inflated to 
deploy the stent (C), and the balloon is deflated and removed along with the catheter and 
guide wire, leaving behind the implanted stent, the compressed plaque, and the widened 
coronary artery (D). The stent lattice is made up of segments known as stent struts. [15] 
Reprinted from [15] with permission. See Appendix P. 
 
Although stenting is currently a principal treatment for CHD, there are notable 
drawbacks to stenting. The first stents developed were bare metal stents (BMSs) and were 
intended to reduce the restenosis that occurs after PTCA. BMSs prevent elastic recoil of 
blood vessels and limit negative remodeling of blood vessels [21, 33], but BMSs do not 
prevent neointimal formation. Blood vessels treated with BMSs may still experience 
neointimal formation, and neointimal formation in the stented region of a blood vessel 
causes in-stent restenosis [33]. To ameliorate in-stent restenosis, drug-eluting stents 
(DESs) were developed. DESs are metal latticed tubes coated with an agent that prevents 
cell proliferation. Because the proliferation of vascular smooth muscle cells in the intima 
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causes neointimal formation, blood vessels treated with DESs experience reduced 
neointimal formation [18]. But blood vessels treated with DESs may also experience 
thrombosis. Therefore, although BMSs and DESs both improve upon previous 
technology, they also both have disadvantages. Because of these disadvantages, 
researchers continue improving stent technology. 
New stent technology currently under development is the dual drug-eluting stent 
(DDES). Since blood vessels treated with DESs may experience thrombosis, DDESs 
were developed as an improved version of DESs: like DESs, DDESs contain an agent 
that prevents cell proliferation, but unlike DESs, DDESs also contain an agent that 
prevents thrombosis [34]. Studies on DDESs are promising: one study showed that a 
DDES containing sirolimus for treating restenosis and triflusal for treating thrombosis 
significantly reduced restenosis compared to BMSs and DESs when implanted in a pig 
for 30 days, and the reduction in restenosis was associated with an inhibition of 
inflammation and thrombus formation [34]; another study showed that a DDES 
containing sirolimus and probucol required less revascularization compared to DESs 
when implanted in humans for two years [35]. Therefore, DDESs may be an 
improvement over previous stent technology. 
Another improvement over previous stent technology may be the bioabsorbable 
stent. Bioabsorbable stents prop open occluded blood vessels for a defined period of time, 
ideally completely dissolve after the defined period of time, and ideally leave behind a 
fully healed natural blood vessel [18]. An advantage of bioabsorbable stents is the 
restoration of natural vascular remodeling after stent dissolution: after deployment of 
BMSs, DESs, and DDESs, vascular remodeling freezes in the stented region of the blood 
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vessel, but after deployment and dissolution of a bioabsorbable stent, natural vascular 
remodeling may be restored [36]. Another advantage of bioabsorbable stents is the 
minimization of late stent thrombosis: after deployment of DESs, late stent thrombosis 
can occur, but after deployment of a bioabsorbable stent, the bioabsorbable stent may 
dissolve before late stent thrombosis occurs and may therefore avoid late stent thrombosis 
altogether [18]. Studies on bioabsorbable stents are promising: one study showed 
complete dissolution of a bioabsorbable stent deployed in human coronary arteries for 
two years [37]. Because bioabsorbable devices are currently considered a revolutionary 
technology in the field of interventional cardiology [38], researchers continue improving 
bioabsorbable stents. 
 
1.7. Coronary Device Testing 
There are a number of coronary devices currently under development for the 
identification and treatment of CHD, including hybrid intravascular imaging systems, 
drug-delivering balloons, DDESs, and bioabsorbable stents. But the Food and Drug 
Administration (FDA) requires that these coronary devices be tested before they are 
marketed in the United States. The FDA approves a coronary device for market only after 
technical data from non-clinical and clinical studies show that the coronary device is safe 
and effective. Non-clinical studies, also known as preclinical studies, refer to in vitro 
laboratory studies and in vivo animal studies, and clinical studies refer to in vivo human 
studies. To help researchers carry out coronary device studies that are well designed in 
the eyes of the FDA, the FDA publishes recommendations for the design of coronary 
device studies [39]. FDA recommendations emphasize that in various cases coronary 
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devices should be preclinically tested specifically under the conditions that exist in 
complex-shaped vessels. 
 
1.7.1. FDA Recommendations for In Vitro Studies 
FDA recommendations for various in vitro engineering studies emphasize that 
coronary devices should be tested in complex-shaped simulated vessels [39, 40]. For 
some in vitro studies, the FDA recommends that a coronary stent intended for 
deployment in a coronary bend be tested in a simulated vessel that is bent to a worst-case 
clinically relevant radius of curvature; the FDA usually recommends a 15-millimeter 
radius of curvature because this represents the worst-case radius of curvature in 90% of 
patients [40]. For other in vitro studies, the FDA recommends that a coronary stent 
intended for deployment in a coronary bifurcation be tested in a simulated vessel that has 
a geometry based on relevant clinical situations [40]. For other in vitro studies, the FDA 
recommends that coronary delivery catheters be tested in simulated vessels that are 
tortuous, and the specific degree of tortuosity is shown in Figure X2.4 of ASTM F2394 
[40]. 
 
1.7.2. Synthetic Models of Coronary Vasculature 
Researchers seeking FDA approval of their coronary devices test their devices in 
complex-shaped simulated vessels. Complex-shaped simulated vessels range from simple 
tubes that can be bent into desired geometries to physiologically accurate replications of 
coronary vasculature [41-43]. One example of a complex-shaped simulated vessel is 
found on the Interventional Device Testing Equipment 2000 (IDTE2000) made by 
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Machine Solutions, Inc.; the IDTE2000 features simple tubing that can be bent to model 
complex geometries of coronary arteries (Figure 1.7 A and B) [41]. Another example of a 
complex-shaped simulated vessel is the Angio-Suite Training Model produced by United 
Biologics, Inc.; the Angio-Suite Training model is a physiologically accurate replication 
of many arteries in the human body, including major coronary arteries (Figure 1.8) [43]. 
The simple tubing of the IDTE2000, the physiologically accurate Angio-Suite Training 
Model, and other complex-shaped simulated vessels may be used to assess various 
aspects of coronary devices. 
 
 
Figure 1.7. A complex-shaped simulated vessel. The IDTE2000 by Machine Solutions, 
Inc. (A) features simple tubing that can be bent into complex geometries (B). [41] 
Reprinted from [41] with permission. See Appendix P. 
 
A 
 
B 
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Figure 1.8. A physiologically accurate complex-shaped simulated vessel. The Angio-
Suite Training Model by United Biologics, Inc. includes silicone coronary arteries. [43] 
Reprinted from [43] with permission. See Appendix P. 
 
Aspects of coronary devices that may be assessed in complex-shaped simulated 
vessels include the following: the ability of a coronary stent to conform to a complex-
shaped vessel after the stent is deployed, also known as flexibility [44]; the ability of a 
coronary stent and delivery system to bend when negotiating a complex-shaped vessel, 
also known as flexibility [44]; the uniformity of a stent after deployment [44]; the ability 
of a balloon to be deflated and withdrawn from a deployed stent, also known as balloon 
deflatability [44]; the force needed to move a coronary device through a tortuous path, 
also known as track force [41]; the ability of a catheter tip to track over a bent guidewire, 
also known as trackability [44]; the force needed to withdraw a coronary device from a 
tortuous path, also known as retractability force [41]; the coating integrity of a coronary 
DES after deployment of the DES in a complex-shaped vessel [39]; the formation of 
particulate matter during tracking and deployment of a coronary DES in a complex-
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shaped vessel [39]; and image distortion that may occur when intravascular imaging 
devices negotiate bent vessels [45]. 
Although these complex-shaped simulated vessels provide researchers with 
valuable information about coronary device performance, these bench testing systems do 
not predict biologic responses that may occur when using coronary devices in human 
patients. One way to predict some biologic responses is to expose coronary devices or 
parts of devices to biologic samples in a laboratory. But most in vitro laboratory tests 
cannot predict complex biologic responses such as the human tissue response to a three-
dimensional coronary stent. 
 
1.7.3. In Vivo Animal Models 
After coronary devices undergo and “pass” in vitro tests in complex-shaped 
simulated vessels and in vitro tests involving exposure to biologic samples, in vivo 
animal testing is used to predict complex biologic responses that may occur when using 
coronary devices in human patients. Various animals may be used to model complex 
biologic responses. Rats have carotid arteries and an abdominal aorta that may be used to 
assess thrombus formation and neointimal responses after stent implantation [46, 47]; 
also, rats may be useful for assessing proliferative responses [48]. Rabbits have iliac 
arteries that may be used to assess the mechanisms of repair after injury to an abnormal 
artery [48]. Porcine models have a coronary artery system that is similar in size and 
structure to humans and that can be used to assess events after stent implantation such as 
injury, neointimal development, and thrombosis [49, 50]. Porcine models are currently 
the closest to humans [48]. 
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An ideal animal model would perfectly predict the following human tissue 
responses. First, during coronary stent deployment, the stent immediately contacts the 
endothelium and removes endothelial cells from the vessel wall, exposing smooth muscle 
cells beneath the endothelium [51, 52]; this event is known as endothelial denudation. 
Immediately after stent deployment, the stent is susceptible to thrombosis for an acute 
period. Acute inflammation then occurs, and inflammatory cells reach the stented site. 
Migration and proliferation of vascular smooth muscle cells begin [53], and vascular 
smooth muscle cells synthesize extracellular matrix proteins and eventually cause 
neointimal formation. Finally, vascular remodeling occurs, and endothelial cells grow 
over the entire inner surface of the stented region of blood vessel [51]. This endothelial 
cell growth is known as re-endothelialization and is key to successful healing after stent 
implantation. A confluent monolayer of endothelial cells modulates local hemostasis and 
thrombolysis, protects vascular smooth muscle cells from circulating growth-promoting 
factors, synthesizes growth factors that are important in vascular smooth muscle cell 
proliferation, and plays a role in the quiescence of smooth muscle cells [52]. Although 
researchers use animal models to predict these human tissue responses, animal tissue 
responses can vary from human tissue responses (Figure 1.9 A and C) [51, 54]. 
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Figure 1.9. Re-endothelialization of a stent in a rabbit iliac artery. On the day of stent 
implantation, blood cells but not endothelial cells are visible on the stent (A). 28 days 
after stenting, a confluent monolayer of endothelial cells has formed, and re-
endothelialization of the stent is complete (C). In human coronary arteries, complete re-
endothelialization of coronary stents has been observed 96 days after stenting. [51, 54] 
Reprinted from [54] with permission. See Appendix P. 
 
Although animal models are widely used to assess complex biologic responses to 
coronary devices, there are notable drawbacks. Sometimes the tissue response of all 
available animal models can be quite different from the human tissue response [48, 55, 
56]. Also, studies involving animal models are expensive and time-consuming. There are 
currently many coronary devices under development that require testing—hybrid 
intravascular imaging systems, drug-delivering balloons, DDESs, and bioabsorbable 
stents are just a few examples described previously—and possibly many prototypes of 
these coronary devices will first be developed, each prototype requiring animal testing to 
ensure that the best prototype is selected. But it is not feasible to test all coronary device 
prototypes in animals because of the expense and time consumption of animal testing, 
therefore some prototypes with outstanding in vivo performance may be overlooked. To 
improve in vivo animal testing, these drawbacks should be ameliorated. 
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1.7.4. Blood Vessel Mimics 
There are a number of drawbacks to all the preclinical testing systems described 
so far. Bench tests involving complex-shaped simulated vessels do not predict biologic 
responses that may occur when using coronary devices in human patients. Most in vitro 
tests involving exposure of coronary devices or parts of devices to biologic samples do 
not predict some complex biologic responses such as the human tissue response to a 
three-dimensional coronary stent. Animal models may exhibit tissue responses that are 
quite different from human tissue responses, and studies involving animal models are 
expensive and time-consuming. These drawbacks prevent the best possible preclinical 
assessments of coronary devices, therefore researchers aim to develop preclinical testing 
systems that ameliorate these drawbacks. 
A preclinical testing system was recently developed that ameliorates some of the 
previously described drawbacks: the blood vessel mimic (BVM). A BVM is a tissue 
engineered blood vessel, consisting of a tubular scaffold that has human endothelial cells 
lining the inner surface. Up until now, BVMs have been developed in straight geometries. 
BVMs have been used to specifically test the re-endothelialization of stents: stents have 
been deployed in BVMs, cells from the BVMs have re-endothelialized the stents, and 
BVMs have identified stents that exhibit better re-endothelialization than other stents. 
Unlike the in vitro testing methods described previously, BVMs feature the ability to 
evaluate re-endothelialization of a three-dimensional stent. Unlike the in vivo animal 
models described previously, BVMs feature a human tissue response, cost-effectiveness, 
and high-throughput screening. [57-59] 
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1.8. Complex-Shaped Blood Vessel Mimics 
Although BVMs do ameliorate some of the previously described drawbacks to 
preclinical testing systems, these mimics could still be modified to better align with 
specific FDA recommendations. As described, the FDA has recommended that in various 
cases coronary devices be preclinically tested in simulated vessels that mimic the 
complex geometries of coronary arteries [40]. The FDA has made this recommendation 
when the complex geometries of coronary arteries create conditions that can negatively 
affect coronary device performance. If the complex geometries of coronary arteries 
negatively affect re-endothelialization of coronary stents, the FDA may recommend that 
BVMs be developed in complex geometries to more accurately assess the unique re-
endothelialization that occurs. 
The complex geometries of coronary arteries may in fact negatively affect re-
endothelialization of coronary stents. When a coronary stent is deployed in a coronary 
bend, the stent may be more rigid than the artery and straighten out the bend [60]. This 
straightening skews the blood velocity profile at the bend and creates regions of 
decreased endothelial shear stress [61, 62]. In regions of low shear stress, the 
endothelium re-establishes itself more slowly [63]. If there are large regions where the 
endothelium has not re-established itself, these large areas of endothelial denudation are 
associated with intimal thickening [64]. Intimal thickening is the cause of in-stent 
restenosis, and coronary arteries that have been straightened with stents are associated 
with in-stent restenosis and major adverse clinical events [60]. Also, when a coronary 
stent is deployed in a coronary bifurcation, stent struts may remain suspended over the 
ostia of branch vessels, not contacting any part of the vessel wall. Stent struts suspended 
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over coronary ostia have been shown to not re-endothelialize (Figure 1.10), and stents 
deployed in coronary bifurcations have been associated with late stent thrombosis [65]. 
Therefore, bent and bifurcated coronary geometries may negatively affect re-
endothelialization of coronary stents and may lead to adverse events after stent 
implantation. 
 
 
Figure 1.10. Re-endothelialization of a stent in a coronary bifurcation. Coronary stents 
were implanted in porcine coronary bifurcations. Some stent struts that were suspended 
over coronary ostia exhibited no re-endothelialization 7 days after implantation. [65] 
Reprinted from [65] with permission. See Appendix P. 
 
Because the complex geometries of coronary arteries may in fact negatively affect 
re-endothelialization of coronary stents, the currently straight BVMs should be 
redeveloped in complex geometries for coronary stent testing. Complex-shaped BVMs 
may more accurately assess the re-endothelialization of coronary stents and may better 
align with FDA recommendations. 
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1.9. Summary and Aims of This Thesis 
Due to the prevalence of coronary heart disease, many new coronary devices are 
being developed. The FDA requires that these coronary devices be tested before they are 
marketed in the United States, and preclinical tests are carried out first. It is advantageous 
to have preclinical testing methods that are high-throughput and cost-effective, that assess 
human tissue responses to three-dimensional coronary devices, and that take into account 
other conditions such as coronary geometry. Current BVMs have many of these 
characteristics but do not mimic the complex geometries of coronary arteries. Therefore, 
complex-shaped BVMs should be developed for coronary stent testing. 
There are multiple potential challenges that could hinder development of a 
complex-shaped BVM. First, complex-shaped scaffolds and bioreactors that can house 
complex-shaped scaffolds have not been fully developed. Second, the technique currently 
used to deposit cells onto a straight scaffold may result in no cell deposition in certain 
regions of complex-shaped scaffolds. Third, when fluid is flowing through scaffolds, an 
extremely angulated scaffold exhibits more than 7 times the wall shear stress of a straight 
scaffold [66]; higher wall shear stress in a complex-shaped scaffold may reduce cell 
retention on the scaffold, possibly hindering formation of any confluent cell lining 
throughout the scaffold. Fourth, some current straight BVMs have been developed using 
human umbilical vein endothelial cells (HUVECs), which are known to only grow in 
monolayers [67], and coronary stents have been shown to completely denude the 
endothelium—which is a monolayer—in human coronary arteries [51, 68]; therefore, 
stent deployment may completely denude a monolayer of HUVECs in a complex-shaped 
BVM. If a complex-shaped BVM that was developed using only HUVECs exhibits 
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denudation after stent deployment, it may be advantageous instead to use cell types that 
are known to form multiple cell layers so that the cells could eventually be cultivated into 
a multilayer that would withstand stent deployment better than a monolayer. Research in 
the following chapters addresses all these potential challenges. 
The goal of this thesis research was to develop a complex-shaped BVM for 
coronary stent testing. To achieve this goal, the following overall hypothesis was 
established: a BVM could be developed in the complex geometries of coronary arteries. 
This hypothesis was tested by conducting research with the following five specific aims. 
 
1. Design, construct, and validate complex-shaped scaffolds and bioreactors. 
a. Hypothesis: complex-shaped scaffolds could be designed and constructed, 
bioreactors capable of housing the new scaffolds could be designed and 
constructed, and cells would deposit onto the new scaffolds inside the new 
bioreactors. 
2. Deposit cells throughout the entire inner surface of complex-shaped scaffolds. 
a. Hypothesis: after 1 day of cultivation of complex-shaped BVMs, no statistically 
significant differences would exist between the cell densities along the length of 
the BVMs, between the cell densities in the inner and outer halves of the BVMs, 
or between the cell densities in the top and bottom halves of the BVMs. 
3. Determine whether HUVECs can reach confluence on a complex-shaped scaffold 
using a cultivation protocol similar to the straight-BVM cultivation protocol. 
a. Hypothesis: after deposition of HUVECs onto U-shaped scaffolds and cultivation 
similar to the straight-BVM protocol, cells would reach confluence. 
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4. Determine whether a complex-shaped BVM that was developed using only HUVECs 
would exhibit denudation of its cell lining after coronary stent deployment. 
a. Hypothesis: a complex-shaped BVM that was developed using only HUVECs 
would exhibit no cell lining after coronary stent deployment. 
5. Develop a confluent region of cells in a U-shaped BVM. 
a. Hypothesis: a confluent region of cells would form in a U-shaped BVM. If 
research addressing the fourth specific aim showed that a complex-shaped BVM 
that was developed using HUVECs may exhibit denudation of its cell lining after 
coronary stent deployment, the confluent region of cells had to be developed 
using a cell type known to form multiple cell layers so that the cells could 
eventually be cultivated into a multilayer that could withstand stent deployment 
better than a HUVEC monolayer. 
 
Experiments were conducted to test all these hypotheses, and findings from these 
experiments are described in the following chapters. Chapter 2 describes the design, 
construction, and validation of complex-shaped scaffolds and bioreactors that can house 
complex-shaped scaffolds. Chapter 3 describes the consistency of cell deposition 
throughout various regions of complex-shaped scaffolds. Chapter 4 describes the effect of 
flow rate on cell confluence in complex-shaped BVMs. Chapter 5 describes stent 
deployment in a complex-shaped BVM. Chapter 6 describes the development of a 
confluent region of cells on an extremely angulated scaffold. And chapter 7 concludes 
this research with a summary and discussion. 
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2. Development of Complex-Shaped Scaffolds and Bioreactors 
 
2.1. Introduction 
This chapter addresses the first specific aim of this thesis: design, construct, and 
validate complex-shaped scaffolds and bioreactors that can house complex-shaped 
scaffolds. 
Complex-shaped BVMs will require new scaffolds and new bioreactors. A 
bioreactor is a device that allows conditions to be closely controlled to induce specific 
behavior in the cells or tissues being cultivated [69, 70]. A BVM is created by first 
inserting a scaffold into a bioreactor, then depositing human endothelial cells onto the 
scaffold, and then cultivating the cell-lined scaffold in the bioreactor (Figures 2.1 and 
2.2). Current BVMs have been developed using only straight scaffolds, and the bioreactor 
currently used to cultivate BVMs is capable of housing only these straight scaffolds [71]. 
Complex-shaped scaffolds and bioreactors that can house complex-shaped scaffolds have 
not been fully developed. Therefore, they must be fully designed, constructed, and 
validated. The hypothesis in this chapter was that complex-shaped scaffolds could be 
designed and constructed, that bioreactors capable of housing the new scaffolds could be 
designed and constructed, and that cells would deposit onto the new scaffolds inside the 
new bioreactors. 
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Figure 2.1. Current BVM bioreactor housing a straight scaffold. The bioreactor is made 
entirely of off-the-shelf components. Not pictured here is a snap-on sealable lid for the 
container. Not visible here are the O-rings placed on the external tip of the female luer 
lug panel mounts and lock nuts that secure the external O-rings in place. 
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Figure 2.2. Current straight scaffold and pressure-sodding method. (A) The scaffold for 
BVMs is made of expanded polytetrafluoroethylene (ePTFE), a porous synthetic 
polymer. The scaffold has a blue double stripe across the top and is sutured to two 
fittings. The inner diameter (ID) of human coronary arteries may range between 1.9 and 
4.5 mm [72], so the scaffold has an ID of 4 mm. Cells are deposited onto the scaffold 
using a method known as pressure-sodding: cells are first suspended in media, and the 
cell suspension is then placed in a syringe; the luminal outlet of the bioreactor (B, 
Luminal Outlet) is then closed, the syringe is attached to the luminal inlet (B, Luminal 
Inlet), the cell suspension is pushed into the scaffold lumen, the entire cell suspension 
except the cells is forced out the scaffold pores, and the cells remain lodged in the 
scaffold pores. 
 
 
 
 
 
 
 
 
Female Luer 
Thread 
Barbed Fitting 
 
 
 
 Suture 
 ePTFE Scaffold 
Luminal 
Outlet 
 
 
Luminal 
Inlet 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Extraluminal Outlet 
 
 
 
           B 
 
 
 
           A 
 32 
2.2. Background Information: Previous Designs 
Previous designs were proposed for complex-shaped scaffolds and bioreactors. 
Because the ePTFE scaffold currently used to develop straight BVMs is flexible, 
previous designs proposed that straight ePTFE scaffolds simply be bent into coronary 
geometries. To mimic the specific coronary bends defined by the American College of 
Cardiology and the American Heart Association, previous designs proposed three 
geometries for bent scaffolds: a scaffold bent less than 45 degrees, a scaffold bent 90 
degrees, and a scaffold bent 180 degrees [71]. Some coronary bifurcations observed in 
clinical practice are T-shaped [73], and previous designs proposed that two straight 
ePTFE scaffolds be sutured together in a T-shape to mimic a T-shaped coronary 
bifurcation (Figure 2.3 A). Other coronary bifurcations observed in clinical practice are 
Y-shaped [73], and previous designs proposed that three straight ePTFE scaffolds be 
sutured together in a Y-shape to mimic a Y-shaped coronary bifurcation (Figure 2.3 B). 
Also, previous designs proposed that 5 bioreactors be developed, each tailored to house 1 
of the 5 proposed scaffold geometries (Figure 2.4). 
 
 
Figure 2.3. Construction methods for a T-shaped scaffold (A) and a Y-shaped scaffold 
(B) that were proposed in previous designs. [71] 
  A   B 
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Figure 2.4. Previously proposed designs for bioreactors that can house complex-shaped 
scaffolds. Each bioreactor is tailored to house a specific scaffold geometry. A bioreactor 
was designed to house a scaffold bent less than 45 degrees, which will now be referred to 
as an S-shaped scaffold (A), another bioreactor was designed to house a scaffold bent 90 
degrees, which will now be referred to as an L-shaped scaffold (B), another bioreactor 
was designed to house a scaffold bent 180 degrees, which will now be referred to as a U-
shaped scaffold (C), another bioreactor was designed to house a T-shaped scaffold (D), 
and another bioreactor was designed to house a Y-shaped scaffold (E). [71] 
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2.3. Materials and Methods 
To create new scaffolds and bioreactors, new designs were first established. Then 
the scaffolds and bioreactors were constructed, human endothelial cells were deposited 
onto the complex-shaped scaffolds, the cell-lined scaffolds were cultivated inside the new 
bioreactors, and finally cell coverage of complex-shaped scaffolds was assessed to 
determine whether cells deposited on the complex-shaped scaffolds. 
 
2.3.1. Challenges with Previous Designs 
There are challenges that could arise during construction and use of the proposed 
Y-shaped scaffold. Construction of the proposed bifurcated scaffolds will involve 
suturing by hand, and the suturing proposed in Figure 2.3 A and B could be tedious, 
especially the suturing proposed for the Y-shaped scaffold, thereby increasing the 
difficulty of scaffold construction. Therefore, a simpler scaffold construction method 
should be developed at least for the Y-shaped scaffold. Also, the suture sites in bifurcated 
scaffolds may be susceptible to unwanted leakage when fluid moves through the 
scaffolds, and the Y-shaped scaffold may be more susceptible to leakage than the T- 
shaped scaffold because the Y-shaped scaffold has more sutures. Therefore, the number 
of sutures at least in the Y-shaped scaffold should be reduced. 
There are also challenges that could arise during construction and use of the 
proposed bioreactors. Researchers may want to run multiple stent-testing trials in each of 
the five proposed geometries. For example, trials in T-shaped BVMs could occur one 
week, trials in U-shaped BVMs could occur another week, and trials in L-shaped BVMs 
could occur another week. Researchers would have to construct, store, and maintain a 
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separate set of bioreactors for each scaffold geometry, which could result in significant 
bioreactor construction time, need for significant storage space for the many bioreactors, 
and significant bioreactor maintenance time. Instead, if researchers had bioreactors that 
were each capable of housing all five proposed scaffold geometries, researchers could 
construct a smaller number of these multifunctional bioreactors and reuse the same 
multifunctional bioreactors each week, which would reduce the number of bioreactors 
that must be constructed, stored, and maintained, thereby reducing bioreactor 
construction time, the need for storage space, and bioreactor maintenance time. 
Therefore, a multifunctional bioreactor was developed. 
Because of the challenges that could arise during construction and use of 
particularly the Y-shaped scaffold proposed in previous designs and during construction 
and use of the five bioreactors proposed in previous designs, a new design was created 
for the Y-shaped scaffold, and a design was created for a multifunctional bioreactor. 
Dimensions and materials were then specified for all designs, resulting in final designs 
for complex-shaped scaffolds in all five geometries and final designs for bioreactors that 
could house all five scaffold geometries. 
 
2.3.2. Final Designs for Complex-Shaped Scaffolds 
The new design for the Y-shaped scaffold is described as follows: two straight 
ePTFE scaffolds were sutured together to form a T-shaped scaffold using the same 
method as depicted in Figure 2.3 A, then each end of the crossbar of the “T” was bent 
upwards so that the “T” became a “Y”, resulting in a Y-shaped scaffold with fewer 
sutures than the Y-shaped scaffold proposed in previous designs. With a reduced number 
 36 
of sutures, this new design for a Y-shaped scaffold may make Y-shaped scaffold 
construction less tedious and may reduce the chance of unwanted leakage. Because this 
new design reduced the possible challenges that could occur with the previous design for 
a Y-shaped scaffold, this new design became the final design for a Y-shaped scaffold. 
The previous designs for the other four complex-shaped scaffolds became the final 
designs for those scaffolds. 
Dimensions of the complex-shaped scaffolds are listed as follows. The total 
lengths of S-, L-, and U-shaped scaffolds were 7 cm, 5 cm, and 5.5 cm respectively. The 
stem of the “T” on a T-shaped scaffold was 2.5 cm long, and the crossbar of the “T” was 
6 cm long. Another T-shaped scaffold was bent into a Y-shape without changing any 
dimensions to create a Y-shaped scaffold. All scaffolds had 4-mm IDs. 
 
2.3.3. Final Designs for Bioreactors That Can House Complex-Shaped Scaffolds 
A multifunctional bioreactor was designed (Figure 2.5). Because this 
multifunctional bioreactor design eliminates the possible challenges that could occur with 
the previous bioreactor designs, this design became a final bioreactor design. The 
multifunctional bioreactor was designed without the ability to house Y-shaped scaffolds 
because additional inlets, outlets, or tubing would crowd the bioreactor, making it 
difficult to use; therefore, the previous design for a bioreactor capable of housing only a 
Y-shaped scaffold also became a final bioreactor design (Figure 2.6). To be able to 
develop BVMs in all five proposed geometries, two bioreactors were constructed: a 
multifunctional bioreactor and a bioreactor capable of housing only a Y-shaped scaffold. 
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Figure 2.5. Multifunctional Bioreactor. New positions for inlets and outlets and new 
tubing arrangements and dimensions were designed (A–C); all inlets and outlets are the 
same distance from the top of the container, the luminal outlet is horizontally centered on 
its wall, and C represents both short sides of the container. The multifunctional bioreactor 
houses one scaffold at a time, and any inlets or outlets not being used when a scaffold is 
inserted will be capped off with luer plugs (D–G). Since the FDA has recommended that 
vessels simulating a worst-case bend for coronary stent testing have a 15-mm radius of 
curvature, any inserted U-shaped scaffold will have a 15-mm radius of curvature. 
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Figure 2.6. Bioreactor capable of housing only a Y-shaped scaffold. The general 
arrangement of inlets, outlets, and tubing for this bioreactor were established in previous 
designs, but specific dimensions were not established. Therefore, the design was updated 
to include tubing dimensions (A) and specific locations for all inlets and outlets: the 
luminal outlets will be 3 cm apart, the luminal inlet is horizontally centered on its wall, 
the extraluminal outlet is 3 cm horizontal from the centerline on its wall, and all inlets 
and outlets are located the same distance away from the top of the container as depicted 
in Figure 2.5 C. (B). 
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2.3.4. Construction of Complex-Shaped Scaffolds 
All scaffolds were made of tubular ePTFE with 4-mm IDs (Impra Bard, Inc., 
Tempe, AZ). Latex gloves were worn when handling the ePTFE. All bent scaffolds were 
constructed by simply bending straight pieces of ePTFE into complex shapes: a straight 
ePTFE scaffold that was 7 cm in length was bent into an S-shape, creating an S-shaped 
scaffold; a straight ePTFE scaffold that was 5 cm in length was bent into an L-shape, 
creating an L-shaped scaffold; and a straight ePTFE scaffold that was 5.5 cm in length 
was bent into a U-shape, creating a U-shaped scaffold. A T-shaped scaffold was 
constructed as follows: first, a hole that was 4 mm in diameter was cut out of the center 
of a straight ePTFE scaffold that was 6 cm in length, then the end of another straight 
ePTFE scaffold that was 2.5 cm in length was sutured (6.0 silk suture) onto the hole, 
creating a T-shaped scaffold (Figure 2.7). Another T-shaped scaffold was constructed 
identically to the first one, and each end of the crossbar of the “T” was bent upward to 
form a “Y”, creating a Y-shaped scaffold. The ends of all scaffolds were sutured (2.0 silk 
suture) onto female luer thread barbed fittings (white nylon, 200 series barb, 1/8” ID, 
Value Plastics, Part Number FTLL230-1) as shown in figure 2.2 A. 
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Figure 2.7. Construction of T-shaped scaffold. To suture together two straight pieces of 
ePTFE, the following procedure was followed. First, a suture needle was used to puncture 
the stem (A). The needle was then pushed through the puncture and pulled out the stem 
end that was being sutured. The needle tip was then used to puncture the crossbar as 
shown in B, and the needle tip was pulled through the puncture. The needle tip was then 
used to puncture the stem again in a location that was 1 mm next to the previous puncture 
in the stem, and this technique was repeated around the entire suture site (C). The suture 
was then pulled taut, and 6 overhand knots were tied to secure the suture. 
 
2.3.5. Construction of Bioreactors to House Complex-Shaped Scaffolds 
The bioreactor that currently houses only straight BVMs (Figure 2.1) is made of 
an off-the-shelf polypropylene container, a number of small off-the-shelf plastic parts 
known as fittings, and silicone tubing. Detailed assembly instructions for that bioreactor 
are located in Design and Optimization of a Blood Vessel Mimic Bioreactor System for 
the Evaluation of Intravascular Devices in Simple and Complex Geometries on pages 84–
93 and 212–218 [71]. Those assembly instructions detail the methods for drilling holes in 
the container, attaching fittings, and attaching tubing to the fittings. Identical assembly 
methods were used for construction of the multifunctional bioreactor and for construction 
of the bioreactor capable of housing only Y-shaped scaffolds. But in the case of the 
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multifunctional bioreactor and the bioreactor capable of housing only Y-shaped scaffolds, 
holes were drilled for inlets and outlets in the locations described in Figures 2.5 A and 2.6 
A, fittings were attached in the locations depicted in those figures, and tubing was cut 
with the dimensions depicted in those figures and was placed in the locations depicted in 
those figures. All holes were drilled with a handheld power drill and a 15/64” drill bit. 
The exact materials used to construct each bioreactor are listed in Tables 2.1 and 2.2. A 
protocol for maintenance of multifunctional bioreactors is located in Appendix B. 
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Table 2.1. Materials for Multifunctional Bioreactor 
Component Company Part Number Quantity 
Polypropylene Container Lock & Lock HPL806 1 
Tygon® Silicone Tubing 
(1/8” ID)  Cole-Parmer WU-95702-06 
25.5 inches cut 
according to 
Figure 2.5 A 
Discofix® 1-Way Stopcock B. Braun Medical D100 455980 3 
3-Way Stopcock Value Plastics VPB1000062N 3 
Female Luer Lug Panel 
Mount (1/8” Barb) Value Plastics FTLB230-1 6 
Buna N O-Ring McMaster-Carr 2418T112 12 
Lock Nut Value Plastics LNS-1 6 
Luer Plug Value Plastics MTLLP-1 3 
Female Luer Thread Fitting 
(1/8” Barb) Value Plastics FTLL230-1 5 
Male Luer Lock Fitting 
(1/8” Barb) Value Plastics MTLL230-1 3 
Y-Connector (1/8” Barb) Value Plastics Y230-1 2 
Rotating Luer Lock 
Connector Qosina 17644 
2 or 3 for bent 
or T-shaped 
scaffold 
respectively 
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Table 2.2. Materials for Bioreactor Capable of Housing Only Y-shaped Scaffolds 
Component Company Part Number Quantity 
Polypropylene Container Lock & Lock HPL806 1 
Tygon® Silicone Tubing 
(1/8” ID)  Cole-Parmer WU-95702-06 
21.5 inches cut 
according to 
Figure 2.6 A 
Discofix® 1-Way Stopcock B. Braun Medical D100 455980 3 
3-Way Stopcock Value Plastics VPB1000062N 1 
Female Luer Lug Panel 
Mount (1/8” Barb) Value Plastics FTLB230-1 4 
Buna N O-Ring McMaster-Carr 2418T112 8 
Lock Nut Value Plastics LNS-1 4 
Female Luer Thread Fitting 
(1/8” Barb) Value Plastics FTLL230-1 3 
Male Luer Lock Fitting 
(1/8” Barb) Value Plastics MTLL230-1 3 
Y-Connector (1/8” Barb) Value Plastics Y230-1 2 
Rotating Luer Lock 
Connector Qosina 17644 3 
 
 
2.3.6. Validation of New Scaffolds and Bioreactors 
After construction, the new scaffolds and bioreactors were tested for the ability to 
generate complex-shaped BVMs. If cell deposition occurred on the new scaffolds inside 
the new bioreactors, the designs for the new scaffolds and bioreactors would be validated. 
Only bent scaffolds and multifunctional bioreactors were tested for the ability to 
generate complex-shaped BVMs, and the reason for this is as follows. To be useful for 
coronary stent testing, complex-shaped BVMs need other characteristics in addition to 
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cells deposited on their scaffolds, such as a confluent cell lining and a cell lining that is 
not completely denuded after coronary stent deployment. Development of these other 
characteristics will be discussed in future chapters. But the laboratory techniques for 
developing these other characteristics are likely similar, regardless of the geometry. 
Therefore, instead of testing techniques in all five scaffold geometries, only some 
geometries were first tested to discover techniques that could be used with all scaffold 
geometries. This saved significant time and resources and allowed faster discovery of 
successful techniques. Bent scaffolds were chosen as the scaffolds to first test because the 
suture sites of bifurcated scaffolds presented potential challenges, and these potential 
challenges could prolong discovery of successful techniques that could be used with all 
scaffold geometries. 
To test bent scaffolds and multifunctional bioreactors for the ability to generate 
complex-shaped BVMs, the following steps were carried out. (Note: the following steps 
only summarize the many tissue engineering laboratory steps that must be carried out 
when generating BVMs and that were carried out for this validation test; the many tissue 
engineering laboratory steps will be discussed in future chapters.) First, an S-, L-, and U-
shaped scaffold were each inserted into a multifunctional bioreactor. The scaffolds and 
bioreactors were primed with media, and HUVECs were pressure-sodded onto each 
scaffold. The bioreactors were attached to media reservoirs, placed in an incubator at 
37˚C and 5% CO2, and connected to an 8-roller pump that circulated media through the 
BVMs for 1 day. Then each vessel was removed from its bioreactor, fixed in Histochoice, 
cut in half longitudinally, and stained with the fluorescent nuclear stain bisbenzimide 
(BBI). A fluorescent microscope was used to capture en face images of the luminal 
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surface of each scaffold, and the images were used to determine whether cells deposited 
on each scaffold. 
 
2.4. Results 
Construction of all five complex-shaped scaffolds and the two new bioreactors 
yielded prototypes that will be discussed here. The BBI images that resulted from the 
validation testing of all three bent scaffolds will also be discussed here. 
 
2.4.1. Prototypes of New Scaffolds and Bioreactors 
Construction of bent scaffolds involved nothing more than bending straight 
scaffolds into complex geometries, which was easy. Construction of bifurcated scaffolds 
was also easy: cutting a hole in the middle of a straight scaffold with a razor, puncturing 
ePTFE with a suture needle, placing ePTFE punctures 1 mm next to each other, and tying 
6 overhand knots to secure the sutures were all easy steps. Suturing together two straight 
pieces of ePTFE was a successful method for attaching the two pieces and for creating a 
T-shaped scaffold. Bending both ends of the crossbar of a T-shaped scaffold upward was 
an easy and successful method for creating a Y-shaped scaffold. Placing female luer 
thread barbed fittings inside the ends of all scaffolds and suturing the ends of all scaffolds 
to the female luer thread barbed fittings was also easy. 
Construction of the multifunctional bioreactor and the bioreactor capable of 
housing only Y-shaped scaffolds was similarly easy. Construction of these new 
bioreactors varied only slightly from construction of the current straight-BVM bioreactor: 
for the new bioreactors, additional holes were drilled into the polypropylene container, 
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tubing was cut in different dimensions and attached at different locations, a few more 
stopcocks were added, and luer plugs were used to cap off any inlets or outlets not being 
used when complex-shaped scaffolds were inserted. All stopcocks on both bioreactors 
were easily accessible, therefore the additional tubing on both bioreactors did not crowd 
the bioreactors to the point of stopcocks being difficult to access. 
Insertion of all five complex-shaped scaffolds into the new bioreactors was a 
success. The female luer thread barbed fittings on the ends of each complex-shaped 
scaffold were easy to secure into position on the male-to-male rotating fittings. In the 
multifunctional bioreactor, luer plugs were easy to attach to inlets or outlets not being 
used, and no media flowed through any of the capped-off inlets or outlets in any of the 
three bioreactors throughout the entire validation test. No scaffolds experienced any 
kinking. Prototypes of the new scaffolds and bioreactors are shown in Figure 2.9. 
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Figure 2.9. Prototypes of the new scaffolds and bioreactors. The multifunctional 
bioreactor houses an S-shaped scaffold (A1–A2), an L-shaped scaffold (B1–B2), a U-
shaped scaffold (C1–C2), and a T-shaped scaffold (D1–D2). The bioreactor in E1–E2 
houses only a Y-shaped scaffold. Bioreactor lids were removed for scaffold visibility. 
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2.4.2. Cell Deposition on Complex-Shaped Scaffolds 
The bent scaffolds and multifunctional bioreactor generated S-, L-, and U-shaped 
BVMs, and all BVMs exhibited cell deposition in BBI images (Figure 2.10). 
 
 
Figure 2.10. BBI image showing cell deposition on U-shaped scaffold. BBI causes cell 
nuclei to fluoresce, and en face BBI images show many small dots that each correspond 
to the nucleus of a cell. The many small dots are usually colored blue, but because this is 
a black-and-white image, the many small dots are gray. Five en face BBI images were 
taken of each complex-shaped scaffold, and all 5 images for each scaffold showed cell 
deposition similar to that shown in this image. 
 
 
 
 
 
 
                                 100 µm 
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2.5. Discussion and Conclusions 
Multiple initial steps were taken toward the development of BVMs in complex 
geometries. Previous designs for complex-shaped scaffolds and bioreactors were 
modified and given specific dimensions. The Y-shaped scaffold was redesigned to make 
construction less tedious and to reduce unwanted leakage when fluid moves through the 
Y-shaped scaffold. A multifunctional bioreactor was designed to reduce bioreactor 
construction time, the need for bioreactor storage space, and bioreactor maintenance time. 
Construction of the new scaffolds and bioreactors, insertion of the new scaffolds into the 
new bioreactors, and capping off unused inlets or outlets in multifunctional bioreactors 
were all easily performed. Cells deposited on S-, L-, and U-shaped scaffolds inside 
multifunctional bioreactors, validating the design of these scaffolds and the 
multifunctional bioreactor. These findings support the hypothesis that complex-shaped 
scaffolds could be designed and constructed, that bioreactors capable of housing the new 
scaffolds could be designed and constructed, and that cells would deposit onto the new 
scaffolds inside the new bioreactors. 
Although BBI images showed cell deposition on each bent scaffold, nothing else 
about the cell linings was assessed. It is possible that the cell lining on each bent scaffold 
has characteristics that do not make it useful for coronary stent testing. For example, cells 
may have densely deposited in some regions of each bent scaffold but sparsely deposited 
in other regions. Regions of sparse cell deposition may lead to formation of subconfluent 
cell linings in those regions, which could lead to inaccurate assessments of re-
endothelialization of coronary stents. Therefore, the cell lining on each bent scaffold 
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should be evaluated more closely to determine how well it actually mimics the 
endothelium of native blood vessels. 
Before the cell lining on each bent scaffold is evaluated more closely, an 
alternative step is to validate the bifurcated scaffolds. But at this point, validation of the 
bifurcated scaffolds may simply prolong the development of any fully functional 
complex-shaped BVM. Closer evaluation of the cell lining on each bent scaffold may 
provide information that is vital to the development of successful techniques that could 
be used with all scaffold geometries, thereby expediting development of a fully 
functional complex-shaped BVM. Therefore, bifurcated scaffolds were not validated at 
this point. 
In conclusion, complex-shaped scaffolds can be constructed, bioreactors capable 
of housing complex-shaped scaffolds can be constructed, and endothelial cells can be 
deposited within complex-shaped scaffolds. The validated bent scaffolds and validated 
multifunctional bioreactors were next used to further develop complex-shaped BVMs. 
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3. Consistency of Cell Deposition on Complex-Shaped Scaffolds 
 
3.1. Introduction 
This chapter addresses the second specific aim of this thesis: deposit cells 
throughout the entire inner surface of complex-shaped scaffolds. 
There are multiple characteristics of straight BVMs that make them useful for 
stent testing. One of these characteristics is a confluent cell lining [31]. A native human 
blood vessel features an endothelium, which is a confluent lining of endothelial cells on 
the inner surface of the blood vessel. When a coronary stent is deployed in a coronary 
artery, the stent denudes the endothelium in the stented region [51, 68]. Endothelial cells 
in the intact region of endothelium next to the stented region begin to migrate into the 
denuded region and eventually onto the stent [74], and this migration of endothelial cells 
is the predominant source of cells involved in re-endothelialization [74]. When a stent is 
deployed in a straight BVM, cells that have not been denuded from the cell lining of the 
BVM re-endothelialize the stent [31]. Therefore, complex-shaped BVMs should also be 
developed with a confluent endothelial cell lining so that a stent can denude some 
endothelial cells but still leave behind intact endothelial cells that will re-endothelialize 
the stent. 
A confluent cell lining may be difficult to form on a complex-shaped scaffold, 
and the reason for this is described as follows. A confluent cell lining in a straight BVM 
does not form as soon as cells are pressure-sodded onto the ePTFE scaffold [59]. When 
endothelial cells are first deposited onto the scaffold, the cells are balled-up, and the cell 
lining is not confluent (Figure 3.1 A) [59]. After a few days of cultivation under flow, the 
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balled-up cells begin to spread out [59], the cells begin to physically contact each other, 
and a confluent cell lining forms when no visible gaps exist between any cells (Figure 3.1 
B). Although cells have deposited on each bent scaffold as described in the previous 
chapter, the consistency of that cell deposition throughout the inner surface of each 
scaffold is unknown—it is possible that cells deposited unevenly. Cells in regions with 
possibly dense cell deposition may have to only spread out to contact neighboring cells, 
whereas cells in regions with sparse cell deposition may have to spread out but also 
migrate to contact neighboring cells. Therefore, regions of dense cell deposition may 
form a confluent cell lining faster than regions of sparse cell deposition, possibly 
resulting in a complex-shaped BVM with a cell lining that is confluent in some regions 
and subconfluent in other regions. If a stent were deployed in one of these unevenly 
confluent complex-shaped BVMs, subconfluent regions of the BVM may not fully re-
endothelialize the stent, while confluent regions may fully re-endothelialize the stent, 
resulting in uneven re-endothelialization and possibly an inaccurate portrayal of that 
stent’s ability to re-endothelialize. Therefore, it is desirable for cells to deposit evenly on 
a complex-shaped scaffold. 
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Figure 3.1. Cross-sections of straight BVM. The ePTFE scaffold is the large beige curve 
in each image, and the cells are small dark dots in A and a very thin dark line on the inner 
surface of the scaffold in B. (A) After 1 day of cultivation, cells appear balled-up, cell 
coverage on the scaffold is sparse, and the cell lining is not confluent. (B) After 7 days of 
cultivation, cells appear spread out, and the cell lining is confluent. [59] 
 
There are various ways that cells may deposit unevenly on a complex-shaped 
scaffold. HUVECs will be pressure-sodded onto complex-shaped scaffolds, and when the 
cell suspension is injected into the complex geometries, cells may not deposit evenly 
along the length of the scaffolds. In a bent scaffold, cells may deposit only at the 
proximal portion of the bend, resulting in no cell lining at the distal end of the bend 
(Figure 3.2). In a bifurcated scaffold, the cell suspension could completely leak out of the 
suture sites and never reach the vessel segments after the bifurcation, resulting in no cell 
lining after the bifurcation. On L- and U-shaped scaffolds, cells may deposit more 
densely on the outer wall of the bends than on the inner wall of the bends. When all 
complex-shaped scaffolds are inserted horizontally into their bioreactors, cells may 
deposit more densely on the bottom half of the scaffolds than on the top half of the 
  A   B 
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scaffolds due to the force of gravity pulling cells downward during pressure-sodding. For 
these reasons, cell deposition on complex-shaped scaffolds was assessed in more detail in 
this chapter. 
 
 
Figure 3.2. Possible cell deposition in bent scaffolds. Black arrows indicate the flow 
direction of the injected cell suspension. Cells may deposit only in the proximal blue 
regions. 
 
To save time and resources and allow for faster discovery of successful laboratory 
techniques as in the previous chapter, only L- and U-shaped scaffolds were assessed 
because bifurcated scaffolds had not undergone validation testing and because the FDA 
has recommended testing coronary stents in simulated vessels with worst-case 
angulations and the American College of Cardiology and the American Heart Association 
do not define the S-shaped scaffold geometry as “angulated” [3, 40]. The hypothesis in 
this case was that, after 1 day of cultivation of complex-shaped BVMs, no statistically 
significant differences would exist between the cell densities along the length of the 
BVMs, between the cell densities in the inner and outer halves of the BVMs, or between 
the cell densities in the top and bottom halves of the BVMs. 
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3.2. Materials and Methods 
3 L-shaped BVMs and 3 U-shaped BVMs were tissue-engineered, using 
laboratory techniques that will be detailed in this section. The laboratory techniques were 
carried out over a 2-week period, and a protocol that identifies when the laboratory 
techniques were used is located in Appendix H. The density of cells in various regions 
throughout each BVM was quantified, and it was determined whether cell densities were 
statistically significantly different along the length of each scaffold geometry, between 
the inner and outer halves of each scaffold geometry, and between the top and bottom 
halves of each scaffold geometry. 
 
3.2.1. Cell Culture 
HUVECs (Lonza) were cultured and expanded in T75 and T225 BD cell culture 
flasks. Cells were cultured in HUVEC media; the components of the HUVEC media and 
steps that were carried out to make the media are located in Appendix C. The cells were 
maintained at 37˚C and 5% CO2 in a small incubator with 80–100% humidity (Shellab 
CO2 Series Incubator, Sheldon Manufacturing, Inc.). During each passage from one flask 
to another flask, cells were monitored using an inverted light microscope (Olympus 
CKX31 with IX2–SLP contrast slider). When cells were pressure-sodded onto scaffolds, 
cells were no more than P8. Enough cells were cultured so that approximately 1.5 million 
cells/cm2 were sodded onto each scaffold. 
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3.2.2. Sterilization and Media Preparation 
All scaffolds were made of 4-mm-ID ePTFE. 3 straight pieces of ePTFE were cut 
to lengths of 5 cm to serve as L-shaped scaffolds, and 3 straight pieces of ePTFE were cut 
to lengths of 5.5 cm to serve as U-shaped scaffolds. Female luer thread barbed fittings 
were inserted into both ends of each scaffold, and both ends of each scaffold were sutured 
onto the fittings using 2.0 silk suture as described in Section 2.3.4. The scaffolds were 
then placed in sterilization pouches, were sterilized in an autoclave for 30 minutes at 
250˚C, and were then dried for 30 minutes. 3 forceps and a degassing flask with a rubber 
stopper were also sterilized in the autoclave. 3 luer plugs and 2 rotating male-to-male luer 
lock connectors were placed loose inside each of the polypropylene containers of 6 
multifunctional bioreactors. The bioreactors with their loose fittings, 6 lids for each of the 
bioreactors, and 6 two-port lids for media reservoirs were sterilized with ethylene oxide 
gas (EtO) at the Cal Poly Veterinary Clinic. 
Throughout the tissue engineering of straight BVMs, three types of media are 
used, and these three types of media were also used for L- and U-shaped BVMs in this 
study. The three types of media are bioreactor media, conditioning media, and HUVEC 
media. 2 bottles of bioreactor media were made for use in this study, 1 bottle of 
conditioning media was made for use in this study, and 1 bottle of HUVEC media in 
addition to the bottle used during cell culture was made for use in this study. The 
components included in each type of media and the steps that were carried out to make 
each type of media are located in Appendices C, D, and E. 
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3.2.3. Denucleation and Protein-Coating of Scaffolds 
All 6 scaffolds were denucleated and coated with protein. First, 60 mL of 
conditioning media was warmed in a water bath at 37˚C, placed in the sterilized 
degassing flask, and placed under vacuum. 6 15-mL conicals were each filled with 10 mL 
of sterile 70% ethanol (EtOH), and each scaffold was placed fully submerged in one of 
the 15-mL conicals for 10 minutes. During the first 30 seconds of submersion, the 
conicals were tapped to dislodge air bubbles on the scaffolds. 6 other 15-mL conicals 
were each filled with 10 mL of sterile 100% EtOH, and each scaffold was moved from 
the 70% EtOH directly into the 100% EtOH using forceps. The scaffolds were fully 
submerged again, and the conicals were tapped again during the first 30 seconds of 
submersion to dislodge air bubbles on the scaffolds. 6 other 15-mL conicals were each 
filled with 10 mL of degassed conditioning media, and each scaffold was moved from the 
100% EtOH directly into the degassed conditioning media; scaffolds were gently 
submerged in the degassed conditioning media to prevent formation of air bubbles during 
submersion. The scaffolds were placed in an incubator at 37˚C overnight. 
 
3.2.4. Insertion of Scaffolds into Bioreactors and Priming 
All media was warmed in a water bath at 37˚C. The 6 sterilized multifunctional 
bioreactors, the 6 sterilized lids for each bioreactor, the 6 sterilized two-port lids for 
media reservoirs, and 2 sterilized forceps were gathered. The 6 15-mL conicals, 
containing 6 scaffolds that had been denucleated and protein-coated, were placed inside a 
laminar flow hood (Nuaire Labgard Class II Type A2 Biological Safety Cabinet). Two 
sterile bioreactors were placed inside the laminar flow hood, and approximately 200 mL 
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of bioreactor media were poured into both bioreactors. Forceps were used to transfer each 
scaffold out of its conical and into a bioreactor. Sterile gloves were then donned, the 
loose luer plugs were secured into position to cap off any inlets or outlets that would not 
be used when a U-shaped scaffold was inserted, rotating male-to-male luer lock 
connectors were secured into position for a U-shaped scaffold, and the scaffold was 
secured into position to form a U-shape (Figure 3.3). Securement of luer plugs, rotating 
male-to-male luer lock connectors, and U-shaped scaffold was also carried out in the 
other bioreactor. Lids were then placed on both bioreactors, and sterile gloves were 
removed. 
The scaffolds were then primed with conditioning media. A syringe was filled 
with 10 mL of conditioning media and attached to the inlet of the U-shaped scaffold on 
one of the bioreactors. The syringe was used to inject 5 mL of conditioning media into 
the lumen of the scaffold, removing all air bubbles from the lumen. The luminal outlet of 
the scaffold was then closed off, and the remaining 5 mL of conditioning media in the 
syringe were forced into the lumen of the scaffold but also through the pores of the 
scaffold. These priming steps were repeated for the U-shaped scaffold in the other 
bioreactor. 
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Figure 3.3. Insertion of U-shaped scaffold into bioreactor. All fittings were secured into 
place, and the scaffold was secured in a U-shape. All scaffolds were positioned with the 
blue double stripe upward (see double blue stripe on top of scaffold in image). 
 
The reservoirs with two-port lids were then primed. 45 mL of conditioning media 
were placed into a 50-mL conical for each reservoir. Two-port lids were then attached to 
each conical, and the conicals were inverted so that media flowed through the tubing 
attached to the conicals, removing all air from inside the tubing. Each two-port lid was 
then connected to one of the bioreactors so that the inlet and outlet of the two-port lids 
were correctly connected to the inlet and outlet of the bioreactors (Figure 3.4). 
The bioreactors and their respective two-port lids were placed in a large incubator 
(Shellab CO2 Incubator) at 37˚C and 5% CO2 and attached to a peristaltic pump (Cole-
Parmer Masterflex L/S Model 8-Roller) (Figure 3.5). First, the luminal outlets and 
luminal inlets of both bioreactors were opened so that media could be pumped through 
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the complex-shaped BVM system to remove any remaining air bubbles from the systems. 
The pump was turned on to 10 rpm, which corresponds to 0.8 mL/min, media was 
pumped through the systems, and all air bubbles were removed from the systems. The 
luminal outlet was then closed, and media was pumped transmurally through the systems 
for 10 minutes at 150 rpm, which corresponds to 12 mL/min. All inlets and outlets were 
then closed to prevent media backflow. The two systems were left in the large incubator. 
 
 
Figure 3.4. Media reservoirs. After air bubbles are removed from the reservoir tubing, 
the tubing is connected to a bioreactor. 
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Figure 3.5. Complex-shaped BVM systems connected to a pump. The pump circulates 
media through the 3 complex-shaped BVM systems shown here. Media flows from the 
reservoirs to the pump to the bioreactors. 
 
These steps were repeated with two more bioreactors, one bioreactor housing a U-
shaped scaffold and the other bioreactor housing an L-shaped scaffold. These steps were 
then repeated a third time with the last two bioreactors, both bioreactors housing L-
shaped scaffolds. Completion of all the steps resulted in 6 primed complex-shaped BVM 
systems: 3 complex-shaped BVM systems containing U-shaped scaffolds and 3 complex-
shaped BVM systems containing L-shaped scaffolds. 
 
3.2.5. Pressure-Sodding of HUVECs 
Cell culture was carried out so that 6 confluent T225 flasks would be available on 
the day that cells were sodded onto the scaffolds. 1 T225 flask of HUVECs was allotted 
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for each scaffold. After all 6 complex-shaped BVM systems were primed, the 6 flasks 
were removed from the small incubator, and the cells in each flask were inspected. Cells 
were removed from the bottom of each flask using trypsin. The suspensions of cells in 
each flask were transferred to their own 50-mL conicals. Each conical was centrifuged on 
setting 4 for 4 minutes to pellet all cells at the bottom of each conical. 
After a pellet of cells formed, the conical was taken to the laminar flow hood, and 
the supernatant was aspirated out of the conical without aspirating out the pellet of cells. 
The cells were resuspended in 4 mL of HUVEC media. A complex-shaped BVM system 
was then brought out of the large incubator and into the laminar flow hood. The reservoir 
was placed to the side in the hood so that the bioreactor could be easily accessible during 
pressure-sodding. The bioreactor outlet was disconnected from the tubing that leads to 
the reservoir and was placed into a media trough so that media could flow out of the 
bioreactor outlet and into the media trough. The luminal outlet was closed, and the 
extraluminal outlet was opened. Two other troughs were prepared: one trough containing 
10 mL of HUVEC media and another trough containing the 4 mL of cell suspension. A 
syringe was filled with 5 mL of HUVEC media and attached to the stopcock proximal to 
the scaffold, and all 5 mL of HUVEC media in the syringe were injected into the tubing 
proximal to the scaffold to remove conditioning media from the proximal tubing. Then 
another syringe was filled with the 4 mL of cell suspension, the syringe was attached to 
the stopcock proximal to the scaffold, and all 4 mL of cell suspension were injected 
transmurally into the scaffold. The syringe used to previously inject HUVEC media was 
used to inject the remaining HUVEC media transmurally into the scaffold. Then all inlets 
and outlets were closed to prevent media backflow, and the bioreactor outlet was 
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reconnected to the reservoir tubing. The reservoir containing conditioning media was 
replaced with a reservoir containing HUVEC media. The complex-shaped BVM system 
was reattached to the pump in the large incubator, and the pump was immediately turned 
on to a setting of 10 rpm (0.8 mL/min) and administered transmural flow. 
These pressure-sodding steps were repeated for each of the 6 scaffolds. 
 
3.2.6. Cultivation 
Transmural flow at 10 rpm (0.8 mL/min) was maintained on all complex-shaped 
BVMs for 1 hour. Then the luminal outlet on all bioreactors was opened, and luminal 
flow at 10 rpm (0.8 mL/min) was maintained for another hour. Luminal flow was then 
increased to 15 rpm (1.2 mL/min) and maintained overnight until the complex-shaped 
BVMs were harvested the next day. 
 
3.2.7. Harvesting and Fixation 
After 1 day of cultivation, all complex-shaped BVMs were harvested from their 
bioreactors. First, all inlets and outlets on each bioreactor were closed off. Then the pump 
was turned off. All bioreactors were removed from the large incubator to a nonsterile 
surface. Six 15-mL conicals were each filled with 8 mL of Histochoice and labeled for a 
specific complex-shaped BVM; the bottom end of each conical was marked “Proximal,” 
and the top end of each conical was marked “Distal” to keep track of proximal and distal 
ends of each complex-shaped BVM. The lid of each bioreactor was removed, and a razor 
blade was used to cut the ends of each complex-shaped BVM off the female luer thread 
barbed fittings, making sure to not do anything that could disrupt the cell lining of each 
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BVM. Forceps were used to transfer each complex-shaped BVM into the corresponding 
15-mL conical of Histochoice, orienting each complex-shaped BVM to align with the 
orientation markings on the outside of each conical. All complex-shaped BVMs remained 
in Histochoice overnight to ensure that fixation occurred. All media in each bioreactor 
and reservoir was disposed of, residual ePTFE scraps on the female luer thread barbed 
fittings in each bioreactor were disposed of, and all bioreactors, bioreactor lids, two-port 
lids, and tubing were cleaned with hot water, dried, and stored for future experiments. 
 
3.2.8. BBI Imaging 
After 1 day of fixation in Histochoice, all complex-shaped BVMs were cut into 
smaller pieces for analysis of cell deposition in various regions. First, each BVM was cut 
into 5 segments (Figure 3.6 A and B). Recall that during scaffold insertion into the 
bioreactors, the blue double stripe on each piece of ePTFE was positioned upward. Each 
scaffold segment was cut in half longitudinally so that each half had one of the blue lines 
that originally formed the double blue stripe. Enough 15-mL conicals were wrapped in 
foil so that each cut segment was individually stored in its own conical; each conical was 
labeled with information that identified the specific segment that would be stored in that 
conical (e.g. “L-Shaped BVM #1, P1, inner”). A BBI solution was prepared as described 
in Appendix G, 1 mL of BBI solution was placed in each conical, and 1 scaffold segment 
was placed in each conical. En face BBI images were taken of each scaffold segment on a 
fluorescent microscope (Olympus BX41) using the protocol included in Appendix G. 4 
images were taken of each scaffold segment: 2 images on the top half of each segment 
and two images on the bottom half of each segment (Figure 3.6 C). 
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Figure 3.6. Cutting of L- and U-shaped BVMs into segments for evaluation. L- and U-
shaped BVMs were first cut into 5 segments: Proximal 1 (P1), Proximal 2 (P2), Middle 
(M), Distal 1 (D1), and Distal 2 (D2); black arrows indicate the direction of flow (A and 
B). C shows an alternate view of segment P1 from both scaffold geometries; the black 
arrow indicates the direction of flow, the vertical red line indicates the demarcation 
between inner and outer halves of the BVMs, and the 4 black boxes indicate the location 
of 4 BBI images that were captured on each BVM segment. Because 6 complex-shaped 
BVMs were tissue-engineered for this study, and because each BVM was cut into 10 
segments, there were a total of 60 scaffold segments that were evaluated. Because 4 BBI 
images were captured on each segment, a total of 240 BBI images were captured for this 
study. 
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3.2.9. Cell Counting in BBI Images 
After BBI images were obtained for all segments of all complex-shaped BVMs, 
cells were counted in the images. Instead of counting all cells in every image, a template 
was applied to every image that highlighted the same small 5 regions in each image 
(Figure 3.7). One person counted cells in these regions by identifying cells with the naked 
eye and keeping a tally of the number of cells that were identified. 
 
 
Figure 3.7. Cell counting in BBI images. 5 small white boxes were placed across the 
center of each image; each small white box has an area of 10,000 µm2. Each blue dot 
represents the nucleus of a cell, and the blue dots were counted in each small white box. 
Note that cells in the top edge of the image are blurry; no small white boxes contained 
any blurry cells, and no blurry cells were counted. The counts from the small white boxes 
were averaged to yield a representative count for the image, and the average was 
converted to a representative density in units of cells/cm2. 
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Just before images were taken of each scaffold segment, the edge of each scaffold 
segment was blotted on a Kimwipe to wick residual BBI solution from the luminal 
surface of the scaffold segments; this method was repeatedly used with any scaffold 
segments whose blue dots were difficult to visualize on the microscope. Even after 
repeated blotting with a Kimwipe, the blue dots in 20 images taken on the outer half of 
one of the U-shaped BVMs were still difficult to visualize. Therefore, cells were not 
counted in those 20 images. Of the total 240 images that were captured in this study, cells 
were counted in 220 images, and the 20 images taken on that outer half of one of the U-
shaped BVMs were not included in the following statistical analysis. 
 
3.2.10. Statistical Analysis of BBI Images 
After representative cell densities were determined for the 220 BBI images, the 
cell densities in different regions of the complex-shaped BVMs were compared to each 
other to determine whether any cell densities were statistically significantly different 
from each other. The number of images taken for L-shaped BVMs totaled to 120, and the 
number of images taken for U-shaped BVMs totaled to 100. Since a representative cell 
density was associated with each image, the number of representative cell densities for L-
shaped BVMs totaled to 120, and the number of representative cell densities for U-
shaped BVMs totaled to 100. To determine if the data set for L-shaped BVMs and the 
data set for U-shaped BVMs were each normally distributed, normal probability plots 
were generated for both data sets using Minitab 16.1.1. If a data set was normally 
distributed, a one-way analysis of variance (ANOVA) was used to determine whether 
statistically significant differences existed between the cell densities in various regions of 
 68 
the scaffold. If a data set was not normally distributed, the Kruskal-Wallis test was used 
to determine whether statistically significant differences existed between the cell 
densities in various regions of the scaffold. Boxplots and individual value plots were 
created so that the differences between cell densities in various regions of each scaffold 
could be better visualized. 
 
3.3. Results 
A sample BBI image for each of the 6 complex-shaped BVMs is shown in Figure 
3.8, and some representative cell counts are summarized in Table 3.1. Appendix I 
includes additional BBI images, the representative cell counts that were established for 
all 220 BBI images, and the method used to convert representative cell counts into cell 
densities with units of cells/cm2. 
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Figure 3.8. Sample BBI images from the 6 complex-shaped BVMs in this study. A 
sample BBI image is shown for each of the three L-shaped BVMs (A–C) and each of the 
three U-shaped BVMs (D–F). D shows blue splotches instead of blue dots. 
 
Table 3.1. Average Cell Counts ± SD for an Area of 10,000 µm2 Along Length of BVMs 
 
BVM Distal 2 Distal 1 Middle Proximal 2 Proximal 1 
L-shaped 31 ± 2 33 ± 2 33 ± 3 32 ± 2 30 ± 2 
U-shaped 27 ± 4 30 ± 4 30 ± 3 29 ± 3 26 ± 5 
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Almost all BBI images showed blue dots whose edges could be clearly identified. 
But the 20 BBI images taken on the outer half of one of the U-shaped BVMs showed 
blue splotches instead of blue dots (Figure 3.8 D), and the edges of the splotches were 
much less identifiable than the edges of the dots, therefore those 20 images were not 
quantified or included in any statistical analyses. 
The normal probability plots showed that the data set for L-shaped BVMs was not 
normal and that the data set for U-shaped BVMs was normal (Figure 3.9). Because the 
data set for L-shaped BVMs was not normal, the Kruskal-Wallis test was used to 
determine whether statistically significant differences existed between the cell densities 
in various regions of L-shaped scaffolds. Because the data set for U-shaped BVMs was 
normal, a one-way ANOVA was used to determine whether statistically significant 
differences existed between the cell densities in various regions of U-shaped scaffolds. 
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Figure 3.9. Probability plots of data sets for L- and U-shaped BVMs. A 95% confidence 
interval was used. A normal data set has all data points inside the outer blue lines and has 
p > 0.05. The L-shaped BVM data set had p < 0.005 and was therefore not normal. The 
U-shaped BVM data set had p = 0.146 and was therefore normal. 
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For L-shaped BVMs, there was a statistically significant difference between the 
cell densities of the 5 regions along the length of the BVMs, there was a statistically 
significant difference between the cell densities in the inner and outer halves of the 
BVMs, and there was no statistically significant difference between the cell densities in 
the top and bottom halves of the BVMs. For U-shaped BVMs, there was a statistically 
significant difference between the cell densities in the 5 regions along the length of the 
BVMs, there was no statistically significant difference between the cell densities in the 
inner and outer halves of the BVMs, and there was no statistically significant difference 
between the cell densities in the top and bottom halves of the BVMs. Table 3.2 shows the 
p-values for each statistical comparison; when p < 0.05, a statistically significant 
difference existed. Appendix J contains the Minitab output that shows each p-value. 
 
Table 3.2. P-Values for All Statistical Comparisons 
Comparison L-Shaped BVM 
U-Shaped 
BVM 
5 Regions Along 
Length of BVM 0.000 0.008 
Inner vs. Outer 0.011 0.057 
Top vs. Bottom 0.607 0.810 
 
 
Boxplots allowed for better visualization of the differences between cell densities 
in various regions of the complex-shaped BVMs. While the one-way ANOVA compared 
averages in the U-shaped BVM data set, the Kruskal-Wallis test compared medians in the 
L-shaped BVM data set. Therefore, U-shaped BVM boxplots were constructed based on 
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averages, while L-shaped BVM boxplots were constructed based on medians. In some 
cases, individual value plots were constructed to show the specific data points that were 
used to construct boxplots. Although the cell densities were statistically significantly 
different between the 5 regions along the length of both L- and U-shaped BVMs and 
between the inner and outer halves of L-shaped BVMs, boxplots showed that all the 
median cell densities throughout L-shaped BVMs and all the average cell densities 
throughout U-shaped BVMs fell between 250,000 cells/cm2 and 350,000 cells/cm2 
(Figures 3.10–3.17). 
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Figure 3.10. Boxplot of cell density along length of L-shaped BVMs. Asterisks mark 
outliers, and the center line of each structure corresponds to a median cell density. 
 
 
Figure 3.11. Individual value plot of cell density along length of L-shaped BVMs. The 
cell densities in this plot were used to create the boxplot in Figure 3.10. 
 75 
 
Figure 3.12. Boxplot of cell density in inner and outer halves of L-shaped BVMs. The asterisk 
marks an outlier, and the centerline of each structure corresponds to a median cell density. 
 
 
Figure 3.13. Boxplot of cell density in top and bottom halves of L-shaped BVMs. Asterisks 
mark outliers, and the center line of each structure corresponds to a median cell density. 
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Figure 3.14. Boxplot of cell density along length of U-shaped BVMs. The center line of 
each structure corresponds to an average cell density. 
 
 
Figure 3.15. Individual value plot of cell density along length of U-shaped BVMs. The 
cell densities in this plot were used to create the boxplot in Figure 3.14. 
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Figure 3.16. Boxplot of cell density in inner and outer halves of U-shaped BVMs. Asterisks 
mark outliers, and the center line of each structure corresponds to an average cell density. 
 
 
Figure 3.17. Boxplot of cell density in top and bottom halves of U-shaped BVMs. The 
center line of each structure corresponds to an average cell density. 
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3.4. Discussion and Conclusions 
Consistency of cell deposition throughout complex-shaped scaffolds was 
quantitatively assessed in this chapter. Consistent cell deposition may lead to 
development of a cell lining that is consistently confluent throughout BVMs, which may 
more accurately predict re-endothelialization of coronary stents. Cells were deposited 
onto L- and U-shaped scaffolds, and cell density after 1 day of cultivation was 
statistically significantly different between various regions in both L- and U-shaped 
BVMs. In L-shaped BVMs, cell density was statistically significantly different between 5 
regions along the length of the BVMs and between the inner and outer halves of the 
BVMs. In U-shaped BVMs, cell density was statistically significantly different in 5 
regions along the length of the BVMs. In other cases, cell density was not statistically 
significantly different. In L-shaped BVMs, cell density was not statistically significantly 
different between the top and bottom halves of the BVMs. In U-shaped BVMs, cell 
density was not statistically significantly different between the inner and outer halves of 
the BVMs and between the top and bottom halves of the BVMs. These findings do not 
support the hypothesis that, after 1 day of cultivation of complex-shaped BVMs, no 
statistically significant differences would exist between the cell densities along the length 
of the BVMs, between the cell densities in the inner and outer halves of the BVMs, or 
between the cell densities in the top and bottom halves of the BVMs. 
Although cell densities in some regions of the BVMs were statistically 
significantly different from each other, boxplots showed that the median cell density in L-
shaped BVMs and the average cell density in U-shaped BVMs still fell between 250,000 
cells/cm2 and 350,000 cells/cm2. Human native cell densities may vary, and animals have 
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exhibited a range of endothelial cell densities within the confluent endothelium of a 
single blood vessel: canines have exhibited endothelial cell densities of 95,000 cells/cm2 
in the ventral wall of the aortic arch orifice region but 155,000 cells/cm2 in the lesser 
curvature of the aortic arch orifice region [75], and rabbits have exhibited endothelial cell 
densities of 381,700 cells/cm2 in their thoracic aorta but 401,600 cells/cm2 in their 
abdominal aorta [76]. Because a range of endothelial cell densities has been observed in 
the endothelium of native blood vessels, and because the cell densities in all L- and U-
shaped BVMs were approximately the same order of magnitude as native endothelial cell 
densities, a complex-shaped BVM with the range of cell deposition that was identified in 
this chapter may still result in the development of a confluent cell lining in all regions of 
the complex-shaped BVM. Therefore, the statistically significantly different cell densities 
observed in this study may not necessarily lead to formation of unevenly confluent cell 
linings. 
The statistical analysis of cell deposition that was presented in this chapter could 
be used in future studies. Future studies may result in the development of confluent cell 
linings in complex-shaped BVMs, and the statistical analysis from this chapter could be 
compared to the confluent cell linings to determine whether statistically significant 
differences in cell deposition affect the development of confluent cell linings. If 
statistically significant differences in cell deposition do affect development of confluent 
cell linings, cell deposition methods could be altered to improve development of 
confluent cell linings. 
An issue occurred with the BBI imaging of cells in the outer half of one of the U-
shaped BVMs: the edges of the cells were not clearly defined. A possible explanation for 
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this is as follows. The surface of ePTFE consists of nodes and internodal fibrils (Figure 
3.18), and the cells in Figure 3.8 D appeared to organize in stripes on the scaffold. The 
cells may have settled into the internodal regions, and BBI solution may have also settled 
into the internodal regions and been resistant to blotting with a Kimwipe. The BBI 
solution may not have been completely removed from the internodal regions, resulting in 
BBI images that showed blurry blue dots. Although some BBI images were blurry, most 
showed clearly identifiable blue dots, and the exclusion of the blurry BBI images from 
statistical analyses was not detrimental to obtaining useful information in this study. 
 
 
Figure 3.18. Luminal surface of eTPFE scaffold. Nodes are separated by fibrils. [77] 
 
Although exclusion of the few blurry images was not detrimental to this study, 
there was a possible drawback to the exclusion. The statistical comparison between the 
cell densities in the inner and outer halves of U-shaped BVMs yielded a p-value of 0.057, 
conveying that no statistically significant difference existed between the cell densities in 
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the inner and outer halves of U-shaped BVMs. But 0.057 was only slightly outside the 
range of p-values that would have conveyed that there was a statistically significant 
difference (p < 0.05), and inclusion of the omitted cell density data may have reduced 
0.057 to a p-value less than 0.05. To confirm or refute these results, a larger batch of U-
shaped BVMs could be tissue-engineered, and the statistical comparison could be 
performed again on the new U-shaped BVMs. But additional experiments that assess cell 
deposition should not be attempted before development of a confluent cell lining is 
attempted because development of a confluent cell lining on a complex-shaped scaffold is 
more useful for coronary stent testing than additional cell deposition information. 
In conclusion, statistically significant differences existed between 5 regions along 
the length of L-shaped BVMs, between the inner and outer halves of L-shaped BVMs, 
and between 5 regions along the length of U-shaped BVMs. But cells deposited with 
average or median densities between 250,000 cells/cm2 and 350,000 cells/cm2 throughout 
all regions of L- and U-shaped BVMs, which may be sufficient for formation of a 
confluent cell lining throughout all regions of these complex-shaped BVMs. Therefore, 
development of a confluent cell lining in complex-shaped BVMs was attempted. 
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4. Effect of Flow Rate on Cell Confluence in U-Shaped BVMs 
 
4.1. Introduction 
This chapter addresses the third specific aim of this thesis: determine whether 
HUVECs can reach confluence on a complex-shaped scaffold using a cultivation protocol 
similar to the straight-BVM cultivation protocol. 
A potential first step toward determining whether HUVECs could reach 
confluence on a complex-shaped scaffold was to cultivate complex-shaped BVMs using 
the protocol that causes cells in the current straight BVM to reach confluence. 
Development of a confluent cell lining in the current straight BVM involved cultivation 
of the straight BVM over a period of more than 1 day and also involved adjustment of the 
flow rate of media moving through the straight BVM lumen [59]. After pressure-sodding 
HUVECs onto straight ePTFE scaffolds, straight BVMs were first cultivated for 1 day at 
a flow rate of 1.6 mL/min, and this cultivation yielded cells that appeared balled-up, cell 
coverage that was sparse, and cells that did not reach confluence [59]. After this 1 day of 
cultivation, the flow rate was increased by 1.2 mL/min every hour until the flow rate 
reached 12 mL/min [59]. Straight BVMs were then harvested after 3, 5, and 7 days of 
cultivation [59]. After 3 days of cultivation, some cells were still balled-up, but cells 
started to reach confluence [59]. After 5 and 7 days of cultivation, cells were no longer 
balled-up, and cells had reached confluence [59]. 
Use of the straight BVM protocol to cause cells to reach confluence in complex-
shaped BVMs could present a challenge. In the previous chapter, cells were deposited 
onto L- and U-shaped scaffolds at a density of 1.5 million cells/cm2, but the average or 
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median cell density in the complex-shaped BVMs after 1 day of cultivation under a flow 
rate of 1.2 mL/min was 250,000–350,000 cells/cm2, conveying that approximately 1.2 
million cells/cm2 that were introduced into the complex-shaped scaffolds were not 
adhered to the scaffolds after the 1 day of cultivation under flow. One potential 
explanation for this is that flow pushes cells off complex-shaped scaffolds during 
cultivation. Also, previous work has shown that a 4-mm-ID straight ePTFE scaffold 
exhibits a wall shear stress of 0.225 dynes/cm2 when fluid that has a viscosity similar to 
the viscosity of media flows luminally through the scaffold at a flow rate of 12 mL/min, 
whereas a 4-mm-ID U-shaped ePTFE scaffold exhibits a wall shear stress of 1.75 
dynes/cm2 when the same fluid flows luminally through the scaffold at the same flow 
rate—the wall shear stress of a U-shaped scaffold is more than 7 times the wall shear 
stress of a straight scaffold in this case [66]. Because flow may push cells off complex-
shaped scaffolds, and because U-shaped scaffolds experience higher wall shear stress 
than straight scaffolds under a flow rate of 12 mL/min, a potential outcome after 
cultivation of U-shaped and straight BVMs for 7 days at 12 mL/min is that fewer cells 
remain adhered to U-shaped scaffolds than to straight scaffolds. If this potential outcome 
is true, the fewer cells of U-shaped BVMs may then not be able to reach confluence. To 
safeguard against this potential outcome, slower cultivation flow rates should be tested in 
U-shaped BVMs in addition to testing the 12 mL/min that has been used to cultivate 
straight BVMs. 
The slower cultivation flow rates that are tested should be the least likely flow 
rates that would push cells off scaffolds. A flow rate that would exert no force on cells is 
0 mL/min. No flow may allow more cells to remain adhered to complex-shaped 
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scaffolds, which may result in cells reaching confluence. Another flow rate that may be 
least likely to push cells off scaffolds is a gradually increasing flow rate. Gradually 
increasing flow rates are associated with better retention of cells on scaffolds than 
abruptly increasing flow rates [78, 79]. The protocol for straight BVMs already includes 
a gradually increasing flow rate: after 1 day of cultivation, the flow rate is increased by 
1.2 mL/min every hour until the flow rate reaches 12 mL/min. But a flow rate that 
increases even more gradually could further reduce the chance that flow pushes cells off 
scaffolds. Therefore, complex-shaped BVMs were cultivated for 1 day using a cultivation 
protocol identical to the cultivation protocol described in the previous chapter, then the 
complex-shaped BVMs were further cultivated for up to 7 days at either 0 mL/min, a 
flow rate that gradually increased over multiple days, or almost identical flow rates used 
to cultivate straight BVMs. Cell confluence on the complex-shaped BVMs was assessed 
after 4 and 7 days of cultivation with the goal of showing development of a confluent cell 
lining over time. 
To save time and resources and allow for faster discovery of successful laboratory 
techniques as in the previous two chapters, these experiments were only attempted in U-
shaped BVMs. U-shaped BVMs were chosen because the FDA in various cases has 
recommended that coronary stents be tested in a worst-case clinically relevant radius of 
curvature. The hypothesis in this case was that after deposition of HUVECs onto U-
shaped scaffolds and cultivation similar to the straight-BVM protocol, cells would reach 
confluence. 
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4.2. Materials and Methods 
6 U-shaped BVMs were cultivated in this study. For the first day of cultivation for 
all 6 BVMs, the cultivation protocol described in Section 3.2.6 was used. After the first 
day of cultivation, the BVMs were cultivated as follows: 2 BVMs at 0 mL/min (1 BVM 
for 4 days, 1 BVM for 7 days), 2 BVMs at an increasing flow rate (1 BVM for 4 days, 1 
BVM for 7 days), and 2 BVMs at 12 mL/min (1 BVM for 4 days, 1 BVM for 7 days). 
Each pair of BVMs was tissue-engineered during separate weeks so that each pair of 
BVMs could be attached to a separate pump with pump settings unique to that pair of 
BVMs. Cell culture, BVM cultivation, and BVM evaluation were all performed within a 
3-week period, and a protocol that identifies when various laboratory techniques were 
used throughout the 3-week period is located in Appendix H. Each BVM was evaluated 
using histology, BBI imaging, and scanning electron microscopy (SEM). 
 
4.2.1. Cell Culture 
HUVECs (Lonza) were cultured and expanded in T75 and T225 BD cell culture 
flasks. Cells were cultured in HUVEC media, using the components and steps described 
in Appendix C. The cells were maintained at 37˚C and 5% CO2 in the same small 
incubator described in Section 3.2.1. During each passage from one flask to another flask, 
cells were monitored using the same inverted light microscope described in Section 3.2.1. 
When cells were pressure-sodded onto scaffolds, cells were no more than P8. Enough 
cells were cultured so that approximately 1.5 million cells/cm2 were sodded onto each 
scaffold. 
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4.2.2. Sterilization and Media Preparation 
The 6 scaffolds were made of 4-mm-ID ePTFE, each piece cut to a length of 5.5 
cm. Female luer thread barbed fittings were inserted into both ends of each scaffold, and 
both ends of each scaffold were sutured onto the fittings as described in Section 2.3.4. 
The scaffolds, multifunctional bioreactors and associated fittings, bioreactor lids, two-
port lids, forceps, and a degassing flask were all packaged and sterilized as described in 
Section 3.2.2. Media was prepared as described in Section 3.2.2. 
 
4.2.3. Scaffold Preparation and Priming 
All scaffolds were denucleated and coated with protein as described in Section 
3.2.3. Media was warmed in a water bath at 37˚C. The sterilized multifunctional 
bioreactors, lids, two-port lids for media reservoirs, and forceps were gathered. The 
scaffolds were inserted into multifunctional bioreactors in U-shapes using the same 
techniques as described in Section 3.2.4. 
Scaffolds and reservoirs were primed with conditioning media as described in 
Section 3.2.4. Two-port lids were then connected to the bioreactors so that the inlets and 
outlets of the two-port lids were correctly connected to the inlets and outlets of the 
bioreactors. The complex-shaped BVM systems were attached to a peristaltic pump and 
primed for 10 minutes at 150 rpm (12 mL/min). All inlets and outlets were closed, and 
the complex-shaped BVM systems were left in the large incubator. 
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4.2.4. Pressure-Sodding of HUVECs 
Cell culture was carried out so that 1 T225 flask of HUVECs was devoted to each 
scaffold. After the complex-shaped BVM systems were primed, the T225 flasks were 
removed from the small incubator, and the cells were inspected. Cells were removed 
from the bottom of the flasks using trypsin, and after all cells appeared to detach from the 
flask bottom, trypsin in the flasks was deactivated. The suspension of cells in each flask 
was transferred to its own 50-mL conical, and the conicals were centrifuged for 4 
minutes. After centrifugation, the supernatant in the conicals was aspirated out, and the 
pellets of cells were resuspended as described in Section 3.2.5. 
Complex-shaped BVM systems were then brought out of the large incubator and 
into the laminar flow hood as described in Section 3.2.5. Syringes were each filled with a 
volume of 4 mL of cell suspension, and all 4 mL of cell suspension were injected 
transmurally onto each scaffold. 5 mL of HUVEC media were then injected transmurally 
onto each scaffold. Then all inlets and outlets were closed to prevent media backflow 
from dislodging cells from scaffold pores, and the bioreactor outlets were reconnected to 
the reservoir tubing. The reservoirs containing conditioning media were replaced with 
reservoirs containing HUVEC media, the complex-shaped BVM systems were reattached 
to the peristaltic pump in the large incubator, and the pump was immediately turned on to 
a setting of 10 rpm (0.8 mL/min) to administer transmural flow. 
 
4.2.5. Cultivation 
Transmural flow at 10 rpm (0.8 mL/min) was maintained on all U-shaped BVMs 
for 1 hour. Then the luminal outlet on all bioreactors was opened, and luminal flow at 10 
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rpm (0.8 mL/min) was maintained for another hour. Luminal flow was then increased to 
15 rpm (1.2 mL/min) and maintained overnight. After the first day of cultivation, each 
pair of BVMs was cultivated according to one of the following protocols. For the pair of 
BVMs allotted for cultivation at 0 mL/min, all inlets and outlets of the bioreactors were 
closed, and the pump was turned off and unplugged; 1 of the BVMs was harvested after 4 
days, and 1 of the BVMs was harvested after 7 days. With the latter BVM, new media 
was placed in its reservoir after 3 days, and for 30 minutes every day until harvesting, the 
pump was turned on to 0.8 mL/min (10 rpm) to circulate new media through the lumen of 
the latter BVM. For the pair of BVMs allotted for cultivation at a gradually increasing 
flow rate, the flow rate was increased by 1.2 mL/min (15 rpm) each day until 9 mL/min 
(100 rpm) was achieved after 4 days; 1 of the BVMs was harvested after 4 days, and 1 of 
the BVMs was harvested after 7 days with its media being changed after 3 days. For the 
pair of BVMs allotted for cultivation at 12 mL/min, the flow rate was increased by 1.2 
mL/min (15 rpm) every hour until 12 mL/min (150 rpm) was achieved; 1 of the BVMs 
was harvested after 4 days, and 1 of the BVMs was harvested after 7 days with its media 
being changed after 3 days. 
 
4.2.6. Harvesting and Fixation 
At the end of each time point, BVMs were harvested as described in Section 
3.2.7, including removal of the complex-shaped BVM systems from the large incubator, 
placement of the complex-shaped BVM systems on a nonsterile surface, removal of the 
BVMs from the bioreactors using a razor blade, and fixation of the BVMs in Histochoice. 
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4.2.7. Histologic Analysis, BBI Imaging, and SEM Imaging 
Imaging of all BVMs was conducted with the goal of assessing whether a 
confluent cell lining developed. All BVMs were first cut into the five segments shown in 
Figure 3.6 B. Segments P2 and D1 were histologically analyzed using the protocol located 
in Appendix L. Segments P1, M, and D2 were each cut in half longitudinally so that each 
half had one of the blue lines that originally formed the double blue stripe on the ePTFE 
scaffold. Segments P1, M, and D2 were analyzed via BBI imaging using the protocol 
located in Appendix G, and segment M was analyzed a second time via SEM imaging 
using the protocol located in Appendix K. 
Segments allotted for histologic analysis were each embedded in paraffin wax at 
the Cal Poly Tissue Analysis Laboratory. The segments were oriented in the paraffin wax 
so that cross-sections could be sectioned. Cross-sections of the segments were then 
sectioned at 6–8 µm and stained with hematoxylin and eosin. White light microscopy was 
used to capture histology images of the entire circumference of the cross-sections. The 
detailed protocol used for these histology procedures is located in Appendix L. 
Segments allotted for BBI imaging were stained with BBI solution. The BBI 
solution was prepared according to the protocol located in Appendix G. First, 1 mL of 
BBI solution was placed in enough foil-wrapped 15-mL conicals so that each segment 
was allotted a conical. The conicals were labeled with information that identified the 
specific segment that was stored in that conical (e.g. “U-Shaped BVM, 0 mL/min, 4-day, 
P1, inner”). The segments were left in the BBI solution overnight and then imaged 
according to the protocol located in Appendix G. 4 images were taken of each scaffold 
segment as described in Figure 3.6 C. 
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Segments allotted for SEM imaging were first dehydrated in various dilutions of 
ethanol as described in Appendix K. The segments were then dried overnight in a 
dessicator. Segments were secured onto the specimen stand of a scanning electron 
microscope, and 3 SEM images were captured evenly along the length of each segment. 
 
4.3. Results 
Multiple histologic cross-sections were obtained from each BVM, and a 
representative histologic cross-section from each BVM was selected for inclusion in this 
results section. A representative BBI image and a representative SEM image from each 
BVM were also selected for inclusion in this results section. Histologic cross-sections, 
BBI images, and SEM images for all BVMs showed cells that had not reached 
confluence. Figures 4.1–4.18 show histologic images, BBI images, and SEM images for 
all 6 BVMs, and a summary of the results is located in Table 4.1. 
 
Table 4.1. Effect of Flow Rate on Confluence of Cell Lining in U-shaped BVMs 
Flow Rate 4 Days of Cultivation 
7 Days of 
Cultivation 
Cells Reached 
Confluence? 
0 mL/min Sparse cell coverage (Figures 4.1–4.3) 
Sparse cell coverage 
(Figures 4.4–4.6) No 
Increasing over 
multiple days 
Sparse cell coverage 
(Figures 4.7–4.9) 
Sparse cell coverage 
(Figures 4.10–4.12) No 
12 mL/min Sparse cell coverage (Figures 4.13–4.15) 
Sparse cell coverage 
(Figures 4.16–4.18) No 
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Figure 4.1. Histologic cross-section of a U-shaped BVM cultivated at 0 mL/min for 4 
days. The thick beige porous circle is the ePTFE scaffold, and the small dark purple spots 
on the inner surface of the scaffold are cells. Around the entire circumference of the 
cross-section, cells appear balled-up, cell coverage is sparse, and cells have not reached 
confluence. 
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               Cells 
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Figure 4.2. BBI image of a U-shaped BVM cultivated at 0 mL/min for 4 days. Sparse 
blue dots confirm the sparse cell coverage shown in Figure 4.1. 
 
 
Figure 4.3. SEM image of a U-shaped BVM cultivated at 0 mL/min for 4 days. Thick 
vertical lines are a part of the scaffold known as nodes, and the nodes are separated by 
scaffold fibrils. The few cells confirm the sparse cell coverage shown in Figure 4.1.
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Figure 4.4. Histologic cross-section of a U-shaped BVM cultivated at 0 mL/min for 7 
days. Around the entire circumference of the cross-section, cells appear balled-up, cell 
coverage is sparse, and cells have not reached confluence. 
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Figure 4.5. BBI image of a U-shaped BVM cultivated at 0 mL/min for 7 days. Sparse 
blue dots confirm the sparse cell coverage shown in Figure 4.4. 
 
 
Figure 4.6. SEM image of a U-shaped BVM cultivated at 0 mL/min for 7 days. The few 
cells confirm the sparse cell coverage shown in Figure 4.4.
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Figure 4.7. Histologic cross-section of a U-shaped BVM cultivated at an increasing flow 
rate for 4 days. Around the entire circumference of the cross-section, cells appear balled-
up, cell coverage is sparse, and cells have not reached confluence. 
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Figure 4.8. BBI image of a U-shaped BVM cultivated at an increasing flow rate for 4 
days. Sparse blue dots confirm the sparse cell coverage shown in Figure 4.7. 
 
 
Figure 4.9. SEM image of a U-shaped BVM cultivated at an increasing flow rate for 4 
days. The few cells confirm the sparse cell coverage shown in Figure 4.7.
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Figure 4.10. Histologic cross-section of a U-shaped BVM cultivated at an increasing 
flow rate for 7 days. Air was in the lumen of this BVM just before harvest. Around the 
entire circumference of this cross-section, cells appear fragmented, cell coverage is 
sparse, and cells have not reached confluence. 
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Figure 4.11. BBI image of a U-shaped BVM cultivated at an increasing flow rate for 7 
days. Sparse blue dots confirm the sparse cell coverage shown in Figure 4.10. 
 
 
Figure 4.12. SEM image of a U-shaped BVM cultivated at an increasing flow rate for 7 
days. The few cells confirm the sparse cell coverage shown in Figure 4.10.
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Figure 4.13. Histologic cross-section of a U-shaped BVM cultivated at a flow rate of 12 
mL/min for 4 days. Around the entire circumference of the cross-section, cells appear 
balled-up, cell coverage is sparse, and cells have not reached confluence. 
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Figure 4.14. BBI image of a U-shaped BVM cultivated at a flow rate of 12 mL/min for 4 
days. Sparse blue dots confirm the sparse cell coverage shown in Figure 4.13. 
 
 
Figure 4.15. SEM image of a U-shaped BVM cultivated at a flow rate of 12 mL/min for 
4 days. The few cells confirm the sparse cell coverage shown in Figure 4.13.
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Figure 4.16. Histologic cross-section of a U-shaped BVM cultivated at a flow rate of 12 
mL/min for 7 days. Around the entire circumference of the cross-section, cell coverage is 
still sparse, and cells have not reached confluence. But cells have flattened out. 
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Figure 4.17. BBI image of a U-shaped BVM cultivated at a flow rate of 12 mL/min for 7 
days. Sparse blue dots confirm the sparse cell coverage shown in Figure 4.16. 
 
 
Figure 4.18. SEM image of a U-shaped BVM cultivated at a flow rate of 12 mL/min for 
7 days. The few cells confirm the sparse cell coverage shown in Figure 4.16. 
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Throughout this study, two issues occurred with the complex-shaped BVM 
systems. First, an O-ring inside one of the multifunctional bioreactors broke apart during 
the first day of cultivation. Second, the two-port lid associated with the BVM that was 
exposed to increasing flow and that was harvested after 7 days leaked during priming of 
the two-port lid. Two-port lids have two fittings that are connected to tubing, and media 
leaked from the fittings of the two-port lid during priming of the reservoir. 
 
4.4. Discussion and Conclusions 
Whether HUVECs could reach confluence on a complex-shaped scaffold using a 
cultivation protocol that was similar to the straight-BVM cultivation protocol was 
determined in this chapter. A confluent cell lining has been achieved in a straight BVM 
by pressure-sodding HUVECs onto a straight ePTFE scaffold, then cultivating the 
straight BVM for 1 day at a flow rate of 1.6 mL/min, then increasing the flow rate by 1.2 
mL/min every hour until the flow rate reaches 12 mL/min, and then cultivating the 
straight BVM at 12 mL/min for 6 more days [59]. An identical cultivation protocol was 
used to cultivate U-shaped BVMs, but cells did not reach confluence. Because flow in U-
shaped scaffolds may push more cells off the scaffolds than flow in straight scaffolds, 
possibly resulting in subconfluent cell linings in U-shaped scaffolds, slower flow rates 
were also used to cultivate U-shaped BVMs. But after cultivating U-shaped BVMs using 
0 mL/min and a gradually increasing flow rate that did not exceed 12 mL/min, cells still 
did not reach confluence. Therefore, these findings did not support the hypothesis that 
after deposition of HUVECs onto U-shaped scaffolds and cultivation similar to the 
straight-BVM protocol, cells would reach confluence. 
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These findings do reveal information about the effect of flow rate on cells in U-
shaped BVMs. As seen in the previous chapter, after 1 day of cultivation at a flow rate of 
1.2 mL/min, U-shaped BVMs exhibited dense cell coverage (Figure 4.19 A). Then after 3 
more days of cultivation at a flow rate of 12 mL/min, U-shaped BVMs exhibited 
noticeably sparser cell coverage (Figure 4.19 B). Therefore, U-shaped BVMs may exhibit 
a loss of cells when cultivated at 12 mL/min after the first day of cultivation. But even 
when the 3 additional days of cultivation occurred under no flow at all, U-shaped BVMs 
still exhibited a noticeable loss of cells (Figure 4.19 C). Therefore, flow may not cause 
the noticeable loss of cells; instead, the scaffold may cause the noticeable loss of cells. 
But, although the loss of cells with flow (Figure 4.19 B) does not appear significantly 
larger than the loss of cells without flow (Figure 4.19 C), the loss of cells could be 
statistically significantly larger with flow than without flow. If the loss of cells is 
statistically significantly larger with flow than without flow, flow may still be pushing 
cells off the scaffold even though it may not be noticeable to the naked eye in Figures 
4.19 B and C. 
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Figure 4.19. Cell loss after first day of cultivation of U-shaped BVMs. With 1 day of 
cultivation, U-shaped BVMs exhibit dense cell coverage (A). After an additional 3 days 
of cultivation at a flow rate of 12 mL/min, U-shaped BVMs exhibited a noticeable loss of 
cells (B). But even after the additional 3 days of cultivation under no flow at all, U-
shaped BVMs still exhibited a noticeable loss of cells (C). 
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If flow pushes cells off the scaffold, flow may also be responsible for cells not 
reaching confluence in U-shaped BVMs after 7 days of cultivation. When straight BVMs 
are cultivated for 1 day at a flow rate of 1.6 mL/min and then for 2 additional days at a 
flow rate of 12 mL/min, straight BVMs exhibit sparse cell coverage [59], and sparse cell 
coverage also occurs around the same time point in U-shaped BVMs that have been 
cultivated at almost identical flow rates. But straight BVMs then go on to exhibit a 
confluent cell lining after 7 days of cultivation, while U-shaped BVMs go on to still 
exhibit sparse cell coverage after 7 days of cultivation. A potential explanation for this is 
described as follows. The unique flow in a U-shaped scaffold that results in higher wall 
shear stress may push more cells off the scaffold than the flow in a straight scaffold that 
results in lower wall shear stress, resulting in more spaces of bare scaffold between cells 
on the U-shaped scaffold. Cells on a straight scaffold may then only have to spread out to 
contact neighboring cells, whereas cells on a U-shaped scaffold may have to spread out 
but also migrate to contact neighboring cells. During 7 days of cultivation, cells on the U-
shaped scaffold may have been continuously pushed off the scaffold before contacting 
any neighboring cells and therefore may never have been able to reach confluence, 
whereas cells on the straight scaffold may have been pushed off the scaffold less often, 
were therefore able to contact neighboring cells more easily, and were therefore able to 
reach confluence. Again, this explanation is possible only if the loss of cells between 1 
and 4 days of cultivation is statistically significantly larger with flow than without flow. 
A limitation of the experimental design of this study was that no 1-day U-shaped 
BVMs were developed as controls to monitor cell deposition on the scaffolds. Although 
the multiple 1-day U-shaped BVMs in the previous chapter all exhibited average or 
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median densities between 250,000 cells/cm2 and 350,000 cells/cm2, it is still possible that 
the BVMs described in the current chapter exhibited significantly less cell deposition, 
resulting in subconfluent cell linings. For example, any missteps during pressure-sodding 
may have resulted in significantly less cell deposition. Therefore, it is possible that 
significantly less cell deposition—not high wall shear stress nor the scaffold—caused the 
subconfluent cell linings seen in this chapter. Future studies that aim to assess cell lining 
development over time should therefore always include 1-day control BVMs so that cell 
deposition is monitored. 
Because the protocols for tissue-engineering a U-shaped BVM that were proposed 
in this chapter did not cause cells to reach confluence, one of the proposed protocols must 
be selected as the best proposed protocol and then altered in a way that will likely cause 
cells to reach confluence. The U-shaped BVMs that were cultivated with the flow rate of 
12 mL/min did exhibit flattened cells (Figure 4.16), while U-shaped BVMs that were 
cultivated with the other protocols exhibited no flattened cells. Therefore, the protocol 
that utilized the flow rate of 12 mL/min was selected as the best of the three protocols 
proposed in this chapter. 
Three issues occurred during this study: (1) an O-ring inside one of the 
multifunctional bioreactors broke apart during the first day of cultivation, (2) the two-port 
lid associated with the BVM shown in Figure 4.10 leaked during priming of the two-port 
lid, and (3) cells appeared fragmented in the BVM shown in Figure 4.10. Air was found 
in the lumen of the BVM shown in Figure 4.10, and the cells may have died and 
fragmented as a result of exposure to the air; the air could have entered the complex-
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shaped BVM system via the leak in the two-port lid. Replacement of O-rings in complex-
shaped BVM systems could ameliorate issues 1 and 2 and is described in Appendix B. 
In conclusion, this study showed that cultivation of complex-shaped BVMs using 
the protocol from current straight BVMs does not cause cells to reach confluence. This 
study also showed that U-shaped BVMs may exhibit a noticeable loss of cells between 
the first and fourth days of cultivation whether cultivated at a flow rate of 12 mL/min or 
under no flow at all between the first and fourth days of cultivation. Lastly, this study 
resulted in the development of a cultivation protocol that yielded a U-shaped BVM with 
flattened cells; potential alterations to this protocol were therefore proposed, and an 
alteration was selected and implemented as described in the following chapters. 
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5. Possible Cell Denudation After Stent Deployment in a U-Shaped BVM 
 
5.1. Introduction 
This chapter addresses the fourth specific aim of this thesis: determine whether a 
complex-shaped BVM that was developed using only HUVECs would exhibit denudation 
of its cell lining after coronary stent deployment. 
Two criteria that should be considered when evaluating a potential alteration to 
the selected protocol from the previous chapter are: (1) the ability of the alteration to 
cause cells to reach confluence on U-shaped scaffolds and (2) the ability of the alteration 
to generate U-shaped BVMs capable of exhibiting re-endothelialization of a coronary 
stent. Two potential alterations are (1) the coating of U-shaped scaffolds with something 
that improves cell retention on the scaffold and (2) the use of other cell types that exhibit 
better retention on U-shaped scaffolds than HUVECs. 
Whether the proposed alterations potentially meet the first criterion has been 
determined in previous work. When polytetrafluorethylene (PTFE) is coated with either 
fibronectin, RGD-containing peptide, laminin, or gelatin, attachment of HUVECs 
significantly improves [80]. When PTFE is coated with either fibronectin, RGD-
containing peptide, laminin, gelatin, or collagen type I and/or III, proliferation of 
HUVECs significantly improves [80]. Therefore, coatings affect HUVEC behavior in 
ways that could lead to confluence. Also, the formation of a thick (140-µm) confluent 
cell lining has resulted from the use of human umbilical vein smooth muscle cells 
(HUVSMCs) in combination with HUVECs on straight ePTFE scaffolds: a confluent cell 
lining formed after pressure-sodding HUVSMCs and HUVECs onto straight ePTFE 
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scaffolds, cultivating the cell-sodded scaffolds at a flow rate of 1.6 mL/min for 1 day, 
increasing the flow rate by 1.2 mL/min every hour until a flow rate of 12 mL/min was 
achieved, and cultivating the cell-sodded scaffolds for 6 more days at a flow rate of 12 
mL/min [59]. Therefore, a cell type other than HUVECs may result in the formation of a 
confluent cell lining. These examples show that both proposed alterations may meet the 
first criterion. 
Whether the coating of U-shaped scaffolds potentially meets the second criterion 
can be determined by examining the effect of stent deployment on the native 
endothelium. The native endothelium is a monolayer—a cell lining that is only 1 cell 
thick. When stent deployment was studied in human coronary arteries via SEM, no 
endothelial cells could be found in the implantation zone during the acute phase (< 6 
weeks) [68]. Stent deployment also disrupts the internal elastic lamina beneath the 
endothelium [81], exposing smooth muscle cells beneath the internal elastic lamina [82]. 
Therefore, stent deployment in a U-shaped BVM may completely denude a HUVEC 
monolayer and thin scaffold coating in the implantation zone, resulting in an implantation 
zone that consists of simply a bare scaffold exhibiting poor retention of HUVECs. The 
bare scaffold may then exhibit no re-endothelialization of a coronary stent, suggesting 
that the stent would exhibit poor re-endothelialization when implanted in a native 
coronary artery even though the stent may actually re-endothelialize very well in a native 
artery. Therefore, the coating of U-shaped scaffolds may not meet the second criterion 
and therefore may not be the best alteration to the selected protocol. 
Complete denudation of a HUVEC monolayer in the implantation zone of a U-
shaped BVM is only a prediction. But this prediction may be supported by deploying a 
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stent in a U-shaped BVM that was developed using one of the three proposed protocols 
from the previous chapter and by assessing whether denudation occurs in that BVM. 
Although cell coverage was sparse after cultivation using the three proposed protocols 
from the previous chapter, cells still remained on all the scaffolds. Deployment of a stent 
in one of those U-shaped BVMs could result in images that simply show a bare scaffold, 
suggesting complete denudation of the sparse monolayer of cells, or images that show an 
intact sparse monolayer, suggesting that stent deployment does not cause complete 
denudation. Therefore, to determine whether complete denudation actually occurs, a stent 
was deployed in a U-shaped BVM that was developed using a protocol similar to one of 
the protocols from the previous chapter. The hypothesis in this case was that a complex-
shaped BVM that was developed using only HUVECs would exhibit no cell lining after 
coronary stent deployment. 
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5.2. Materials and Methods 
Two U-shaped BVMs were cultivated in this study using a protocol similar to the 
protocol from the previous chapter that utilized a flow rate of 0 mL/min. After cultivation 
of both BVMs, a stent was deployed in one of the BVMs, while no stent was deployed in 
the other BVM. Cell culture, BVM cultivation, stent deployment, and evaluation of the 
BVMs and stent were all performed within a 4-week period. Both BVMs were evaluated 
using BBI imaging, and the stent was evaluated using SEM imaging. 
 
5.2.1. Cell Culture 
HUVECs (Lonza) were cultured and expanded in T75 and T225 BD cell culture 
flasks. Cells were cultured in HUVEC media (Appendix C). The cells were maintained at 
37˚C and 5% CO2 in a small incubator and monitored using an inverted light microscope. 
When cells were pressure-sodded onto scaffolds, cells were no more than P8. Enough 
cells were cultured so that approximately 1.5 million cells/cm2 were sodded onto each 
scaffold. 
 
5.2.2. Scaffold Sterilization, Scaffold Preparation, and Priming 
The 2 scaffolds were prepared and sterilized as described in Section 4.2.2. The 
scaffolds were denucleated and coated with protein as described in Section 3.2.3. The 
scaffolds were inserted into multifunctional bioreactors in U-shapes. Scaffolds and 
reservoirs were primed with conditioning media as described in Section 3.2.4. Two-port 
lids were then connected to the bioreactors so that the inlets and outlets were correctly 
connected to the inlets and outlets of the bioreactors. The complex-shaped BVM systems 
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were attached to the 8-roller peristaltic pump and primed for 10 minutes at 150 rpm (12 
mL/min). All inlets and outlets were closed, and the complex-shaped BVM systems were 
left in the large incubator. 
 
5.2.3. Pressure-Sodding of HUVECs 
Cell culture was carried out so that 1 T225 flask of HUVECs was devoted to each 
scaffold. After the complex-shaped BVM systems were primed, the T225 flasks were 
removed from the small incubator, and the cells were inspected. The cells were removed 
from the flasks, centrifuged so that they formed a pellet, and resuspended. Syringes were 
filled with the cell suspension, the cell suspension was injected transmurally onto each 
scaffold. All inlets and outlets were closed to prevent media backflow from dislodging 
cells from scaffold pores. The reservoirs containing conditioning media were replaced 
with reservoirs containing HUVEC media, the complex-shaped BVM systems were 
reattached to the peristaltic pump in the large incubator, and the pump was immediately 
turned on to a setting of 10 rpm (0.8 mL/min) to administer transmural flow. 
 
5.2.4. Cultivation 
Transmural flow at 10 rpm (0.8 mL/min) was maintained on both U-shaped 
BVMs for 1 hour. Then the luminal outlet on both bioreactors was opened, and luminal 
flow at 10 rpm (0.8 mL/min) was maintained for another hour. Luminal flow was then 
increased to 15 rpm (1.2 mL/min) and maintained overnight. After the first day of 
cultivation, all inlets and outlets of the bioreactors were closed, and the pump was turned 
off and unplugged. New media was placed in the reservoirs for each BVM every 3 days. 
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After 4, 5, 6, 7, 9, 11, and 13 days of cultivation, the pump was turned on to 0.8 mL/min 
(10 rpm) for 30 minutes to circulate new media through the lumen of the BVMs. After 14 
days of cultivation, one of the BVMs was harvested as described in Section 4.2.6, and a 
stent was deployed in the other BVM as described in the following section. 
 
5.2.5. Stent Deployment 
A bare metal stent (4.0 mm x 38 mm coronary stent, Guidant Corporation) was 
deployed into one of the BVMs after 14 days of BVM cultivation. First, the BVM was 
detached from the pump and taken into the laminar flow hood, and the lid of the 
bioreactor was removed and set aside in the hood. The stent was deployed by inserting a 
stent-loaded balloon catheter into the luminal inlet of the multifunctional bioreactor. The 
stent was visible through the silicone tubing and through the BVM. The tip of the catheter 
scraped the inside of the BVM as the tip negotiated the U-shape. The stent was not 
completely inserted into the BVM—as it did not reach the distal 1 cm of the BVM. The 
inflation device was then triggered in an attempt to inflate the balloon, but instead 15 mL 
of saline solution was injected directly into the BVM lumen because the catheter was set 
up incorrectly. The catheter was reconfigured, the balloon was successfully inflated to 8 
atm, and the pressure was maintained for 10 seconds. The balloon was then deflated, and 
the catheter was removed, leaving behind the deployed stent in the BVM. The lid was 
placed back on the bioreactor, and the complex-shaped BVM system now containing the 
deployed stent was placed back into the large incubator and connected to the pump. 
Luminal flow was maintained at 0.8 mL/min (10 rpm) for 1.5 hours and was then 
increased to 1.2 mL/min (15 rpm) and allowed to run overnight. The next day, the flow 
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rate was increased to 25 rpm and maintained for 1 hour, then increased to 35 rpm and 
maintained for 1 hour, then increased to 60 rpm and maintained for 1 hour, then increased 
to 75 rpm and maintained for 1 hour, and then increased to 100 rpm and maintained for 2 
days. After the 2 days, the pump was turned off, the complex-shaped BVM system was 
removed from the pump, and the stented BVM was harvested from the bioreactor and 
fixed in Histochoice. 
 
5.2.6. BBI and SEM Imaging 
Both BVMs were cut in half longitudinally. After cutting the stented BVM in 
half, the stent halves fell out of the BVM halves. All BVM halves were stained with BBI, 
and en face fluorescent images were captured along the length the BVM halves using a 
fluorescent microscope. Both stent halves underwent the dehydration protocol for SEM 
imaging (Appendix K). The stent halves were then dried overnight in a dessicator, and en 
face images of the stent struts were captured using a scanning electron microscope. 
 
5.3. Results 
A coronary stent was successfully deployed in a U-shaped BVM that was housed 
in a multifunctional bioreactor: the catheter was easily fed into the bioreactor, the stent 
was visible through the silicone tubing and through the U-shaped BVM, and the tip of the 
catheter was able to negotiate the U-shape of the BVM. When the stent was deployed, the 
stent straightened out the U-shaped BVM (Figure 5.1). When the stented BVM was cut in 
half longitudinally, the BVM relaxed away from the more rigid stent (Figure 5.2). 
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Figure 5.1. Stent deployment in a U-shaped BVM. Before stent deployment, the U-
shaped BVM is not straightened out (A). After stent deployment, the stent straightens out 
the U-shape (B). 
 
 
Figure 5.2. Separation of a U-shaped BVM from a rigid coronary stent. The U-shaped 
BVM relaxed away from the stent halves, and eventually the BVM completely separated 
from the stent. 
 
BBI images of the non-stented BVM showed a sparse cell lining similar to the U-
shaped BVMs in the previous chapter (Figure 5.3), whereas BBI images of the stented 
BVM showed no cells (Figure 5.4). SEM images of the stent showed no cell coverage 
(Figure 5.5). 
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Figure 5.3. BBI image of a U-shaped BVM with no implanted stent. A sparse cell lining 
developed similar to the sparse cell lining of U-shaped BVMs in the previous chapter. 
 
 
Figure 5.4. BBI image of a U-shaped BVM after stent implantation. No cells are present 
on the scaffold. 
 
 
 
 
 
 
 
 
 
                                        100 µm 
 
 
 
 
 
 
 
 
 
                                        100 µm 
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Figure 5.5. Stent strut after implantation in a U-shaped BVM. No cells are visible on the 
stent strut. All stent struts appeared this way. 
 
5.4. Discussion and Conclusions 
Deployment of a stent in a U-shaped BVM was performed as described in this 
chapter to determine whether a stent denudes cells from the luminal surface of a U-
shaped BVM. Two U-shaped BVMs were cultivated, and a stent was implanted in one of 
the BVMs. After harvesting, the non-stented BVM exhibited a sparse cell lining similar 
to the sparse cell lining of U-shaped BVMs in the previous chapter, whereas the stented 
BVM exhibited no cell lining of any kind. These findings support the hypothesis that a 
complex-shaped BVM that was developed using only HUVECs would exhibit no cell 
lining after coronary stent deployment, although the cause of the cell loss was not 
determined. Also, no cells appeared on any stent struts, conveying that cells absent from 
the stented BVM were not located on the stent struts. Therefore, stent deployment may 
denude cells from a U-shaped BVM. 
 
 
 
 
 
 
 
 
 
           100 µm 
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This study did not show whether stent deployment actually denuded cells from a 
U-shaped BVM because the stented BVM was assessed 2 days after stent deployment. To 
show whether stent deployment actually denuded cells, the stented BVM should have 
been assessed immediately after stent deployment. But regardless of how stent 
deployment immediately affected the cell lining, no cell lining regenerated anywhere 
throughout the stented BVM 2 days after stent deployment. For a U-shaped BVM to 
convey any information about the tissue response multiple days after stent deployment, 
cells must be present on the scaffold multiple days after stent deployment. Therefore, the 
selected protocol from the previous chapter should be altered in a way that allows at least 
some cells to remain on the scaffold multiple days after stent deployment. 
Since stent deployment may denude a monolayer of cells from a U-shaped BVM, 
possibly resulting in no regeneration of any cell lining multiple days after stent 
deployment, U-shaped BVMs should be developed to better withstand stent deployment. 
A cell type that can form multiple cell layers may allow U-shaped BVMs to withstand 
denudation of a monolayer of cells and then still exhibit re-endothelialization of a stent, 
whereas a thin layer of coating that improves formation of a HUVEC monolayer on U-
shaped scaffolds may be denuded during stent deployment and result in areas of the 
scaffold that exhibit poor retention of HUVECs, possibly leading to a lack of cell 
migration onto the stent and therefore an inaccurate portrayal of the stent’s ability to re-
endothelialize. For these reasons, the first alteration that should be made to the selected 
protocol from the previous chapter should not involve coatings but instead should involve 
a modification of the cell type that is used to tissue-engineer U-shaped BVMs. 
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This study generated other useful information about stent deployment in a U-
shaped BVM. A coronary stent was successfully deployed, which validated the complex-
shaped BVM system for coronary stent testing. Also, during stent deployment, the stent 
straightened out the U-shape of the BVM, and this straightening also occurs when a 
coronary stent is deployed in human coronary arteries [60]. The straightening in human 
coronary arteries creates areas of low endothelial shear stress [61, 62], which may cause 
the endothelium to re-establish itself more slowly [63]. Therefore, the ability of the U-
shaped BVM to mimic the straightening that occurs in native human coronary arteries 
may yield more accurate assessments of stent re-endothelialization. 
A potential issue in this study was that the U-shaped BVM separated from the 
rigid stent when the stented BVM was cut in half. With future U-shaped BVMs that have 
confluent cell linings and that are fully capable of testing stents for re-endothelialization, 
it may be desirable for the stent to remain completely apposed to the BVM wall after 
being cut in half. Cell coverage on the stent may in fact keep the stent completely 
apposed to the BVM wall after cutting, but if cell coverage alone does not secure the 
stent in place, the U-shaped BVM may separate from the rigid stent. This separation 
could disrupt cell coverage on the stent, and the disrupted cell coverage could be falsely 
interpreted as the stent’s poor ability to re-endothelialize. A possible solution to this 
separation is to suture the BVM to the stent struts at various locations along the length of 
the BVM just before cutting so that the two entities do not separate. Also, the separation 
could be avoided altogether by performing plastic embedding instead of the previously 
described cutting method. 
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In conclusion, this study showed that a U-shaped BVM may exhibit cell 
denudation after stent implantation, possibly resulting in no regeneration of any cell 
lining multiple days after stent deployment, this study validated the complex-shaped 
BVM system for coronary stent testing, and this study showed that a U-shaped BVM 
mimics the straightening effect that occurs when coronary stents are implanted into 
human coronary arteries. Because a U-shaped BVM may exhibit cell denudation after 
stent deployment, a U-shaped BVM will next be tissue-engineered using a cell type that 
can form multiple cell layers so that the top layer of cells may be denuded while layers 
beneath remain intact after stent deployment. 
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6. Development of a Confluent Region of Cells in a U-Shaped BVM 
 
6.1. Introduction 
This chapter addresses the fifth specific aim of this thesis: develop a confluent 
region of cells in a U-shaped BVM. Because a complex-shaped BVM may exhibit 
denudation of its cell lining after coronary stent deployment, the confluent region of cells 
must be developed using a cell type that is known to form multiple cell layers. 
To achieve the fifth specific aim of this thesis, two cell types were used. Although 
a cell type that forms multiple layers may allow a U-shaped BVM to better withstand 
stent deployment, cell types that form multiple layers are typically not endothelial cells—
endothelial cells are contact inhibited and form only monolayers [67]. But throughout this 
thesis, BVMs have been developed with the goal of modeling re-endothelialization of 
coronary stents, therefore endothelial cells still must be included in the U-shaped BVM. 
Therefore, to satisfy the new requirement of being able to withstand denudation of a top 
layer of cells, but to still satisfy the original requirement of being able to model re-
endothelialization, two cell types must be used. 
Previous work has resulted in the successful development of straight BMVs by 
sodding two cell types onto a straight scaffold: HUVECs and HUVSMCs. The protocol 
that was used to develop the dual-sodded straight BVM is described as follows. First, 
HUVSMCs were pressure-sodded onto a straight ePTFE scaffold, and the straight BVM 
was transmurally cultivated at a flow rate of 0.8 mL/min (10 rpm) for 30 minutes [59]. 
HUVECs were then pressure-sodded onto the scaffold, and the dual-sodded BVM was 
transmurally cultivated at a flow rate of 0.8 mL/min (10 rpm) for 30 more minutes [59]. 
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The dual-sodded BVM was then luminally cultivated at a flow rate of 0.8 mL/min (10 
rpm) for an hour and then at a flow rate of 1.6 mL/min (20 rpm) overnight [59]. After 
dual-sodded straight BVMs were cultivated for just 1 day, they were harvested [59]. 
Additional dual-sodded straight BVMs were cultivated for more than 1 day, where the 
flow rate was increased by 1.2 mL/min every hour until 12 mL/min (150 rpm) was 
achieved [59]. These dual-sodded straight BVMs were then cultivated for either 3, 5, or 7 
days [59]. After all periods of cultivation—1, 3, 5, and 7 days—confluent cell linings 
formed [59]. After 7 days of cultivation, a multilayer cell lining formed [59]. Because the 
protocol for developing a dual-sodded straight BVM resulted in formation of a confluent 
cell lining, the protocol was used to develop a U-shaped BVM with the goal of 
specifically developing a confluent multilayer region of cells. The hypothesis in this case 
was that a confluent region of cells would form in a U-shaped BVM. 
 
6.2. Materials and Methods 
Dual-sodded straight BVMs exhibited total cell coverage after 1 day of 
cultivation. To be able to compare the results of this study to the dual-sodded straight 
BVMs, dual-sodded U-shaped BVMs were cultivated for 1 day. Previous HUVEC-only 
U-shaped BVMs exhibited dense cell coverage after 1 day of cultivation but sparse cell 
coverage after 4 days of cultivation. To be able to compare the results of this study to 
previous HUVEC-only U-shaped BVMs, additional dual-sodded U-shaped BVMs were 
cultivated for 4 days. In total, 6 dual-sodded U-shaped BVMs were cultivated in this 
study: 3 were cultivated for 1 day, and 3 were cultivated for 4 days. All 6 were cultivated 
using a protocol almost identical to the protocol described in the introduction of this 
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chapter. Cell culture, BVM cultivation, and BVM evaluation were all performed within a 
3-week period. A protocol that identifies when various laboratory techniques were used 
throughout the 3-week period is located in Appendix O. After cultivation, the BVMs 
were evaluated via histology, fluorescence imaging, and SEM imaging. Also, SEM 
images of a previous 1-day HUVEC-only U-shaped BVM were captured so that 1-day 
dual-sodded U-shaped BVMs could be compared to 1-day HUVEC-only U-shaped 
BVMs. 
 
6.2.1. Cell Culture 
HUVECs and HUVSMCs were each cultured and expanded in T75 and T225 BD 
cell culture flasks. HUVECs were cultured in HUVEC media (Appendix C). HUVSMCs 
were cultured in HUVSMC media using the components and steps described in Appendix 
M. The cells were maintained at 37˚C and 5% CO2 in a small incubator and monitored 
using an inverted light microscope. When cells were pressure-sodded onto scaffolds, 
HUVECs were no more than P8, and HUVSMCs were no more than P16. Enough 
HUVECs were cultured so that approximately 1.5 million cells/cm2 were sodded onto 
each scaffold, and enough HUVSMCs were cultured so that approximately 1.5 million 
cells/cm2 were sodded onto each scaffold. To identify HUVECs and HUVSMCs via 
fluorescence microscopy after BVM cultivation, Cell Tracker™ Red dye (Invitrogen, 
catalog number C34522) and Cell Tracker™ Green dye (Invitrogen, catalog number C 
7025) were administered to the T225 flasks of HUVECs and HUVSMCs respectively just 
before the cells were centrifuged. Cell Tracker™ dyes pass freely through cell 
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membranes but then transform into cell-impermeable reaction products. The use of Cell 
Tracker™ will be discussed further in later subsections of this chapter. 
 
6.2.2. Scaffold Sterilization, Scaffold Preparation, and Priming 
6 scaffolds were prepared and sterilized as described in Section 4.2.2. All 
scaffolds were denucleated and coated with protein as described in Section 3.2.3. The 
scaffolds were inserted into multifunctional bioreactors in U-shapes. Scaffolds and 
reservoirs were primed with conditioning media as described in Section 3.2.4. The 
complex-shaped BVM systems were attached to an 8-roller peristaltic pump and primed 
for 10 minutes at 150 rpm (12 mL/min). All inlets and outlets were closed, and the 
complex-shaped BVM systems were left in the large incubator. 
 
6.2.3. Pressure-Sodding of HUVSMCs 
Cell culture was carried out so that 1 T225 flask of HUVSMCs was devoted to 
each scaffold. While complex-shaped BVM systems were being primed, dual-sodding 
media was prepared by simply combining HUVSMC media and HUVEC media, 
resulting in a media that was 25% HUVSMC media and 75% HUVEC media; this 
specific media was used to successfully cultivate previous dual-sodded BVMs [83]. After 
the complex-shaped BVM systems were primed, the HUVSMC T225 flasks were 
removed from the small incubator, and the cells were inspected. The cells were removed 
from the flasks, centrifuged so that they formed a pellet, and resuspended. Syringes were 
filled with the cell suspension, the cell suspension was injected transmurally onto each 
scaffold. All inlets and outlets were closed to prevent media backflow from dislodging 
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cells from scaffold pores. The reservoirs containing conditioning media were replaced 
with reservoirs containing dual-sodding media, the complex-shaped BVM systems were 
reattached to the peristaltic pump in the large incubator, and the pump was immediately 
turned on to 10 rpm (0.8 mL/min) to administer transmural flow for 30 minutes. 
 
6.2.4. Pressure-Sodding of HUVECs 
During the 30 minutes of transmural flow, the HUVEC T225 flasks were removed 
from the small incubator, and the cells were inspected. The cells were removed from the 
flasks, centrifuged so that they formed a pellet, and resuspended. The complex-shaped 
BVM systems were taken off the peristaltic pump, and the cell suspension was injected 
transmurally onto each scaffold. All inlets and outlets were closed, the complex-shaped 
BVM systems were reattached to the peristaltic pump in the large incubator, and the 
pump was immediately turned on to 10 rpm (0.8 mL/min) to administer transmural flow 
for 30 more minutes. 
 
6.2.5. Cultivation 
After the 30 additional minutes of transmural flow, the luminal outlet on all 
bioreactors was opened, and luminal flow at 10 rpm (0.8 mL/min) was maintained for 1 
hour. Luminal flow was then increased to 20 rpm (1.2 mL/min) and maintained 
overnight. After the overnight cultivation, 3 BVMs were harvested, and the flow rate of 
the 3 other BVMs was increased by 15 rpm (1.2 mL/min) every hour until 150 rpm (12 
mL/min) was achieved. This flow rate was maintained until the BVMs were harvested 
after 4 days of cultivation. 
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6.2.6. Histologic Analysis, Fluorescence Imaging, and SEM Imaging 
Imaging of all BVMs was conducted with the goal of assessing whether a 
confluent multilayer cell lining developed. All BVMs were first cut into the 5 segments 
shown in Figure 3.6 B. Segments P2 and D1 were histologically analyzed using the 
protocol located in Appendix K. Segments P1, M, and D2 were cut in half longitudinally 
so that each half had one of the blue lines that originally formed the double blue stripe on 
the ePTFE scaffold. Segments P1, M, and D2 were analyzed via fluorescence imaging 
using the protocol located in Appendix G, and segment M was analyzed a second time 
via SEM imaging using the protocol located in Appendix K. 
The Cell Tracker™ dyes were intended to identify HUVSMCs and HUVECs in 
the cell lining that developed in the BVMs. HUVSMCs were stained with Cell Tracker™ 
Green dye (Invitrogen, catalog number C 7025), and HUVECs were stained with Cell 
Tracker™ Red dye (Invitrogen, catalog number C34522). Stock solutions of Cell 
Tracker™ were prepared by following a previously established protocol [84]; appendix N 
describes the preparation of Cell Tracker™ in more detail. Briefly, Cell Tracker™ 
powder was diluted to a concentration of 10 mM using DMSO to create a stock solution, 
and the stock solution was mixed with media to yield a desired concentration of working 
solution. When white light images of histologic cross-sections were being captured using 
an Olympus BX41 microscope, 2 fluorescent images of the identical fields of view of the 
histologic cross-sections were also captured: 1 fluorescent image was captured so that 
structures fluoresced green, and a second fluorescent image was captured so that 
structures fluoresced red. The white light image and the 2 fluorescent images were then 
compared to determine the location of HUVSMCs and HUVECs in the cell lining. 
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Segments allotted for BBI imaging were stained with BBI solution. The BBI 
solution was prepared according to the protocol located in Appendix G. First, 1 mL of 
BBI solution was placed in enough foil-wrapped 15-mL conicals so that each segment 
was allotted a conical. The conicals were labeled with information that identified the 
specific segment that was stored in that conical. The segments were left in the BBI 
solution overnight and then imaged according to the protocol located in Appendix G. 4 
images were taken of each scaffold segment as described in Figure 3.6 C. 
Segments allotted for SEM imaging were first dehydrated in various dilutions of 
ethanol as described in Appendix K. The segments were then dried overnight in a 
dessicator. Segments were secured onto the specimen stand of a scanning electron 
microscope, and 3 SEM images were captured evenly along the length of each segment. 
Also, SEM images of a previous 1-day HUVEC-only U-shaped BVM were captured. 
 
6.3. Results 
Multiple histologic cross-sections were obtained from each BVM, and two 
representative histologic cross-sections were selected for inclusion in this results section: 
1 histologic cross-section that represents the BVMs cultivated for 1 day, and 1 histologic 
cross-section that represents the BVMs cultivated for 4 days. Representative BBI images 
and SEM images were selected the same way. A dual-sodded U-shaped BVM cultivated 
for 1 day exhibited a confluent region of cells (Figure 6.1), but all other histologic cross-
sections, BBI images, and SEM images for all BVMs showed subconfluent cell linings 
similar to the cell linings in chapter 4. Figures 6.2–6.7 show images for dual-sodded U-
shaped BVMs cultivated in this study for 1 and 4 days. 
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Figure 6.1. Confluent region of cells in a U-shaped BVM cultivated for 1 day. A fully 
confluent region of cells formed on the outer half of segment M in a dual-sodded U-
shaped BVM. All other SEM images from this BVM and from all other 1-day dual-
sodded U-shaped BVMs showed cell coverage as depicted in Figure 6.4. 
 
 
 
 
 
 
 
 
 
           100 µm 
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Figure 6.2. Histologic cross-section of a dual-sodded U-shaped BVM cultivated for 1 
day. The entire circumference of the cross-section is covered with cells, and cells appear 
mostly spread-out. 
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Figure 6.3. BBI image of a dual-sodded U-shaped BVM cultivated for 1 day. Entire 
image is filled with blue dots—no dark spaces devoid of cells appear between blue dots. 
 
 
Figure 6.4. SEM image of a dual-sodded U-shaped BVM cultivated for 1 day. Cell 
coverage is sparse compared to the confluent region of cells in Figure 6.1. 
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                                        100 µm 
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Figure 6.5. Histologic cross-section of a dual-sodded U-shaped BVM cultivated for 4 
days at a flow rate of 12 mL/min. The entire circumference of the cross-section is 
covered with cells, and many cells appear spread-out. More cell coverage is apparent in 
this 4-day dual-sodded U-shaped BVM compared to the 4-day HUVEC-only U-shaped 
BVMs shown in Figures 4.1, 4.7, and 4.13. 
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Figure 6.6. BBI image of a dual-sodded U-shaped BVM cultivated for 4 days at a flow 
rate of 12 mL/min. Blue dots indicate cells. 
 
 
Figure 6.7. SEM image of a dual-sodded U-shaped BVM cultivated for 4 days at a flow 
rate of 12 mL/min. More cell coverage appears in this BVM compared to the 4-day 
HUVEC-only U-shaped BVMs shown in Figures 4.3, 4.9, and 4.15. 
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                                        100 µm 
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In the fluorescent images that were intended to show HUVSMCs fluorescing 
green and HUVECs fluorescing red, the structures that fluoresced green also fluoresced 
red. Therefore, HUVSMCs could not be distinguished from HUVECs in the cell linings 
of any BVMs (Figure 6.8). 
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Figure 6.8. Histologic cross-section showing identical structures fluorescing green and 
red. HUVSMCs were dyed with Cell Tracker™ Green, and HUVECs were dyed with 
Cell Tracker™ Red. The top image is a white light image. 
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6.4 Discussion and Conclusions 
A dual-sodded U-shaped BVM was developed as described in this chapter in an 
attempt to develop a confluent region of cells. After sodding a U-shaped scaffold with 
HUVSMCs and then HUVECs and cultivating the dual-sodded BVM for 1 day, a 
confluent region of cells developed on the outer wall of the middle segment. These 
findings support the hypothesis that a confluent region of cells would form in a U-shaped 
BVM, although it was not consistent throughout the BVM. 
The cell linings on the dual-sodded U-shaped BVMs shown in this chapter were 
the most confluent cell linings developed in a complex-shaped BVM so far, although the 
cell linings were still subconfluent. Dual-sodded U-shaped BVMs exhibited more cell 
coverage than HUVEC-only U-shaped BVMs after both 1 and 4 days of cultivation 
(Figure 6.9). This was likely because HUVSMCs adhere to the U-shaped scaffold better 
than HUVECs. But twice as many cells were sodded onto the U-shaped scaffold through 
the dual-sodding process, therefore dual-sodded U-shaped BVMs also may have 
exhibited more cell coverage because twice as many cells were sodded onto the scaffold. 
Future work should determine whether the HUVSMC cell type or the larger number of 
sodded cells improved cell coverage. 
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Figure 6.9. Comparison of HUVEC-only U-shaped BVMs to dual-sodded U-shaped 
BVMs. Dual-sodded U-shaped BVMs exhibited more cell coverage than HUVEC-only 
U-shaped BVMs after 1 and 4 days, but cell coverage is still sparse in both. 
 
When an almost identical dual-sodding protocol is used to cultivate dual-sodded 
straight BVMs and dual-sodded U-shaped BVMs, the dual-sodded straight BVMs exhibit 
confluent cell linings after 1 day of cultivation, while the dual-sodded U-shaped BVMs 
do not. The same issues(s) that resulted in a lack of confluent cell linings in HUVEC-only 
U-shaped BVMs may have also resulted in a lack of confluent cell linings in dual-sodded 
U-shaped BVMs. One of these issues may be that the unique flow in a U-shaped scaffold 
that results in higher wall shear stress may push more cells off the scaffold than the flow 
 
      100 µm 
 
      100 µm 
    
      100 µm 
 
      100 µm 
Dual-Sodded 
HUVEC-
Only 
1-Day 4-Day 
 138 
in a straight scaffold that results in lower wall shear stress, resulting in more spaces of 
bare scaffold between cells on the U-shaped scaffold. 
An issue with the Cell Tracker™ occurred during this study: although HUVSMCs 
were dyed with Cell Tracker™ Green and HUVECs were dyed with Cell Tracker™ Red, 
the structures that fluoresced green also fluoresced red. A potential explanation for this 
issue is that the BVMs underwent fixation, processing, paraffin-embedding, and staining 
for histology, and this may have affected the Cell Tracker™ in a way that caused the 
outcome in Figure 6.8. Therefore, future work should be carried out to improve Cell 
Tracker™ performance in BVMs that have undergone histology procedures. 
In conclusion, after sodding a U-shaped scaffold with HUVSMCs and then 
HUVECs and cultivating the dual-sodded BVM, a confluent region of cells did develop 
in one area of the dual-sodded U-shaped BVM, but this result was inconsistent. 
Therefore, it is possible that further development of this protocol will result in a confluent 
lining of cells in a U-shaped BVM. 
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7. Discussion and Conclusions 
 
7.1. Review of the Purpose of Complex-Shaped BVMs 
The complex geometries of coronary arteries are prone to lethal plaque formations 
that cause CHD. As a result, CHD is the leading cause of death in the United States, and 
new coronary devices are constantly under development to identify and treat this disease. 
The FDA requires that these devices be tested, but current in vitro and in vivo testing 
methods have drawbacks. In response to these drawbacks, BVMs were developed in 
straight geometries and have been used to identify stents that re-endothelialize better than 
other stents. But in certain cases where the complex geometries of coronary arteries may 
negatively affect coronary device performance, the FDA has specifically recommended 
that coronary devices be tested in complex-shaped simulated vessels. Therefore, BVMs 
should be developed in the complex geometries of coronary arteries. 
 
7.2. Summary of Thesis Work 
The work in this thesis describes the development of complex-shaped scaffolds 
and bioreactors, the development of complex-shaped BVMs with cells located throughout 
all regions of the BVMs, and the development of a U-shaped BVM with a confluent 
region of cells. 
The first aim of this work was to design, construct, and validate complex-shaped 
scaffolds and bioreactors. The hypothesis in this case was that complex-shaped scaffolds 
could be designed and constructed, that bioreactors capable of housing the new scaffolds 
could be designed and constructed, and that cells would deposit onto the new scaffolds 
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inside the new bioreactors. Complex-shaped scaffolds were constructed, bioreactors 
capable of housing the new scaffolds were constructed, and cells deposited on the new 
scaffolds. These results supported the hypothesis. 
The second specific aim was to deposit cells throughout the entire inner surface of 
complex-shaped scaffolds. The hypothesis in this case was that, after 1 day of cultivation 
of complex-shaped BVMs, no statistically significant differences would exist between the 
cell densities along the length of the BVMs, between the cell densities in the inner and 
outer halves of the BVMs, or between the cell densities in the top and bottom halves of 
the BVMs. Although statistically significant differences did exist between 5 regions 
along the length of L-shaped BVMs, between the inner and outer halves of L-shaped 
BVMs, and between 5 regions along the length of U-shaped BVMs, cells did deposit with 
average or median densities between 250,000 cells/cm2 and 350,000 cells/cm2 throughout 
all regions of L- and U-shaped BVMs. Results did not support the hypothesis, but results 
did confirm that cells can deposit throughout all regions of complex-shaped BVMs at 
densities that are approximately the same order of magnitude as endothelial cell densities 
in various native blood vessels. 
The third specific aim was to determine whether HUVECs would reach 
confluence on a complex-shaped scaffold using a cultivation protocol similar to the 
straight-BVM cultivation protocol. The hypothesis in this case was that after deposition 
of HUVECs onto U-shaped scaffolds and cultivation similar to the straight-BVM 
protocol, cells would reach confluence. Cells did not reach confluence using three 
different cultivation protocols, therefore results did not support the hypothesis. But the 
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protocol utilizing the constant flow rate of 12 mL/min did result in development of a U-
shaped BVM with flattened cells. 
After none of the proposed cultivation protocols resulted in development of any 
region of confluence in a U-shaped BVM, the best proposed cultivation protocol was 
selected, and multiple alterations to the protocol were proposed. Alterations that focused 
on coating the U-shaped scaffold or developing a monolayer of endothelial cells on the 
U-shaped scaffold were not desirable because it was suspected that stent deployment 
would denude a thin coating or thin cell lining from the U-shaped scaffold. But because 
denudation after stent deployment in a complex-shaped BVM was only a suspicion, the 
fourth specific aim of this thesis was to determine whether a complex-shaped BVM 
developed using only HUVECs would exhibit denudation of its cell lining after coronary 
stent deployment. The hypothesis in this case was that a complex-shaped BVM that was 
developed using only HUVECs would exhibit no cell lining after coronary stent 
deployment. A U-shaped BVM did exhibit no cell lining after coronary stent deployment, 
therefore the results supported the hypothesis, and potential alterations that involved thin 
coatings or thin cell linings were avoided. The stent deployment study also validated the 
complex-shaped BVM system for coronary stent testing and revealed the U-shaped 
BVM’s important ability to mimic the straightening effect that occurs when coronary 
stents are implanted in human coronary arteries. 
The fifth specific aim of this thesis was to develop a confluent region of cells in a 
U-shaped BVM. Because a complex-shaped BVM exhibited possible denudation of its 
cell lining after coronary stent deployment, the confluent region of cells had to be 
developed using a cell type that was known to form multiple cell layers so that the cells 
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could eventually be cultivated into a multilayer that would withstand stent deployment 
better than a monolayer. The hypothesis in this case was that a confluent region of cells 
would form in a U-shaped BVM. A confluent region of cells did develop in one area of a 
U-shaped BVM, although this result was inconsistent. Therefore, results supported the 
hypothesis. These results revealed that a confluent region of cells can develop in a U-
shaped BVM even though a U-shaped scaffold exhibits more than 7 times the wall shear 
stress of a straight scaffold. Overall, the results from all five aims support the hypothesis 
that a BVM could be developed in the complex geometries of coronary arteries. 
 
7.3. Limitations and Future Work 
Although this thesis has culminated with the development of a confluent region of 
cells in a U-shaped BVM, a confluent cell lining throughout all regions of a complex-
shaped BVM is necessary to predict re-endothelialization of a coronary stent. Therefore, 
future work should focus on the development of a confluent cell lining throughout all 
regions of a U-shaped BVM. Future steps may involve sodding U-shaped scaffolds with 
more cells, sodding a single U-shaped scaffold multiple days in a row so that cells can 
fall off the scaffold but be replaced with new cells, or allowing HUVSMCs to develop 
into a thick cell lining over a longer period and then sodding HUVECs on top of the thick 
HUVSMC lining. No matter what alterations are made to the protocol for the tissue 
engineering of complex-shaped BVMs, a main criterion that should be considered when 
evaluating potential alterations is the ability of the alteration to withstand stent 
deployment and still function usefully after stent deployment. 
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Other future work on complex-shaped BVMs could involve the complete 
development of BVMs in the other proposed geometries. Complete development includes 
validation of the bifurcated scaffolds and the bioreactor capable of housing only Y-
shaped scaffolds, quantification of cell deposition on S-, T-, and Y-shaped scaffolds, 
development of a confluent cell lining on all the complex-shaped scaffolds, successful 
stent deployment in fully functional complex-shaped BVMs, and a repeatable, consistent 
BVM tissue response to coronary stents. 
 
7.4. Conclusions 
In conclusion, complex-shaped scaffolds and bioreactors were fully developed, 
complex-shaped BVMs were developed with cells located throughout all regions of the 
BVMs, and a U-shaped BVM was developed with a confluent region of cells. In addition 
to preclinically testing coronary stents, potential applications of complex-shaped BVMs 
include preclinical testing of drug-delivery systems, coronary imaging modalities, and 
other coronary technologies. Complex-shaped BVMs may eventually improve the 
accuracy of preclinical coronary device testing and result in the development of improved 
coronary devices, which could directly benefit CHD patients. 
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Appendix A: Abbreviations 
 
ACC – American College of Cardiology 
AHA – American Heart Association 
ANOVA – Analysis of variance 
BBI – Bisbenzimide 
BMS – Bare metal stent 
BVM – Blood vessel mimic 
CHD – Coronary heart disease 
DDES – Dual drug-eluting stent 
DES – Drug-eluting stent 
D1 – Distal 1 
D2 – Distal 2 
ePTFE – expanded polytetrafluoroethylene 
ESS – Endothelial shear stress 
EtO – Ethylene oxide 
FBS – Fetal bovine serum 
FDA – Food and Drug Administration 
GA-1000 – gentamicin sulfate amphotericin B 
hEGF – human epidermal growth factor 
HEPES – 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
hFGF-B – human fibroblast growth factor B 
HUVEC – Human umbilical vein endothelial cell 
HUVSMC – Human umbilical vein smooth muscle cell 
ID – Inner diameter 
IDTE2000 – Interventional Device Testing Equipment 
IVUS – Intravascular ultrasound 
M – Middle 
NIRS – Near infrared spectroscopy 
OD – Outer diameter 
P1 – Proximal 1 
P2 – Proximal 2 
P/S – penicillin/streptomycin 
PTCA – Percutaneous transluminal coronary angioplasty 
PTFE – polytetrafluoroethylene 
R3-IGF-1 – long R insulin-like growth factor 1 
SEM – Scanning electron microscopy 
TCFA – thin-cap fibroatheroma 
VEGF – vascular endothelial growth factor 
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Appendix B: Protocol for Maintaining Multifunctional Bioreactor 
 
Purpose 
 
The O-rings of multifunctional bioreactors may degrade and cause leakage during 
bioreactor use, which could ruin an experiment. Therefore, it is important to replace O-
rings on multifunctional bioreactors when the O-rings seem to have started to degrade. 
The following protocol describes how to replace O-rings on multifunctional bioreactors. 
A similar protocol could be used to possibly repair leaky two-port lids. 
 
Components 
 
• Razor blade (rib-back carbon steel, Bard-Parker) 
• Hemostats 
• New O-rings 
 
Picture-Protocol 
 
 
 
Figure B.1. Locate degraded O-rings. 
 
 
  
 
Figure B.2. Wedge razor blade between UV glue and polypropylene container, and start 
to pry off UV glue. 
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Figure B.3. Leave razor blade wedged in place, and wedge hemostats between UV glue 
and polypropylene container. 
 
 
  
 
Figure B.4. Remove razor blade. Use hemostats to pry off UV glue from polypropylene 
container. Use hemostats to unscrew lock nut and to start unscrewing femal luer lug panel 
mount. Finish unscrewing female luer lug panel mount by hand. Replace O-rings. Screw 
female luer lug panel mount back in place. Screw lock nut back in place. Re-apply UV 
glue. 
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Appendix C: HUVEC Media Preparation 
 
Purpose 
 
The following was the list of components used to make HUVEC media and the protocol 
that was followed to make this media. This protocol yielded a single bottle of 515.2 mL 
of HUVEC media. The HUVEC media consisted of 500 mL of endothelial cell basal 
medium and EGM™-2 SingleQuots® made by Lonza with catalog number CC-4176. 
 
Components 
 
• 500 mL endothelial cell basal medium 
• 10 mL fetal bovine serum (FBS) 
• 0.2 mL hydrocortisone 
• 2 mL human fibroblast growth factor B (hFGF-B) 
• 0.5 mL vascular endothelial growth factor (VEGF) 
• 0.5 mL long R insulin-like growth factor 1 (R3-IGF-1) 
• 0.5 mL ascorbic acid 
• 0.5 mL human epidermal growth factor (hEGF) 
• 0.5 mL gentamicin sulfate amphotericin B (GA-1000) 
• 0.5 mL heparin 
 
Protocol 
 
1. In a laminar flow hood, attach filter to bottle. 
2. Attach vacuum to filter. Turn on vacuum. 
3. Pour approximately 400 mL of endothelial cell basal medium into filter, leaving the 
remaining 100 mL to wash down other components from sides of filter. 
4. Add the remaining components into the filter, using a pipette to verify the exact 
quantities of each component. 
5. Wash the filter with the remaining 100 mL of endothelial cell basal medium. 
6. Detach the filter from the bottle. Cap the bottle. Place Lonza label on bottle, and place 
tape label on bottle that includes date and initials. 
7. Place labeled bottle in refrigerator (4˚C). 
8. Before using media from refrigerator, warm media to 37˚C in water bath. 
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Appendix D: Bioreactor Media Preparation 
 
Purpose 
 
The following was the list of components used to make bioreactor media and the protocol 
that was followed to make this media. This protocol yielded a single bottle of 569.4 mL 
of bioreactor media. 
 
Components 
 
• 500 mL M199 
• 56 mL fetal bovine serum (FBS) 
• 5 mL L-glutamine 
• 5 mL penicillin/streptomycin solution (P/S) 
• 0.6 mL fungizone 
• 2.8 mL 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) 
 
Protocol 
 
1. In a laminar flow hood, attach filter to bottle. 
2. Attach vacuum to filter. Turn on vacuum. 
3. Pour approximately 400 mL of M199 into filter, leaving the remaining 100 mL to 
wash down other components from sides of filter. 
4. Add the remaining components into the filter, using a pipette to verify the exact 
quantities of each component. 
5. Wash the filter with the remaining 100 mL of M199. 
6. Detach the filter from the bottle. Cap the bottle. Place tape label on bottle that 
includes “Bioreactor Media,” date, and initials. 
7. Place labeled bottle in refrigerator (4˚C). 
8. Before using media from refrigerator, warm media to 37˚C in water bath. 
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Appendix E: Conditioning Media Preparation 
 
Purpose 
 
The following was the list of components used to make conditioning media and the 
protocol that was followed to make this media. This protocol yielded a single bottle of 
588.6 mL of conditioning media. 
 
Components 
 
• 500 mL M199 
• 83 mL fetal bovine serum (FBS) 
• 5 mL penicillin/streptomycin solution (P/S) 
• 0.6 mL fungizone 
 
Protocol 
 
1. In a laminar flow hood, attach filter to bottle. 
2. Attach vacuum to filter. Turn on vacuum. 
3. Pour approximately 400 mL of M199 into filter, leaving the remaining 100 mL to 
wash down other components from sides of filter. 
4. Add the remaining components into the filter, using a pipette to acquire the exact 
quantities of each component. 
5. Wash the filter with the remaining 100 mL of M199. 
6. Detach the filter from the bottle. Cap the bottle. Place tape label on bottle that 
includes “Conditioning Media,” date, and initials. 
7. Place labeled bottle in refrigerator (4˚C). 
8. Before using media from refrigerator, warm media to 37˚C in water bath. 
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Appendix F: Complex-Shaped BVM Harvesting Protocol 
 
Purpose 
 
The following was the protocol used to remove complex-shaped BVM systems from the 
large incubator and pump and to harvest complex-shaped BVMs from multifunctional 
bioreactors. 
 
Components 
 
• Razor blade (rib-back carbon steel, Bard-Parker) 
• Forceps 
• 8 mL of Histochoice per complex-shaped BVM 
• Complex-shaped BVM system, including complex-shaped BVM 
 
Protocol 
 
1. Put on gloves. 
2. Close all stopcocks on bioreactor, and clamp off inlet and outlet on reservoir. 
3. Detach the complex-shaped BVM system from pump, and move complex-shaped 
BVM system out of large incubator and onto nonsterile surface. 
4. Acquire 15-mL conical for each BVM, and label each 15-mL conical with all 
information necessary to identify the BVM that will be placed in conical and to 
identify the orientation of the BVM after placement in conical. 
5. Fill each conical with 8 mL of Histochoice. Leave conicals uncapped. 
6. Remove bioreactor lid. 
7. Place razor blade at edge of BVM, and cut entirely through BVM, making sure to not 
do anything that could disrupt the cell lining of BVM. Cut other end of BVM. 
8. Use forceps to gently grab end of BVM, and transfer to conical. Place lid on conical. 
9. Remove ePTFE scraps that remain on female luer thread barbed fittings. 
10. Dispose of all media in bioreactor and reservoir. 
11. Clean all bioreactors, bioreactor lids, two-port lids, and tubing with hot water. Dry 
and store equipment for future experiments. 
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Appendix G: BBI Imaging Protocol 
 
Purpose 
 
The following was the protocol used for staining complex-shaped BVMs with BBI and 
for acquiring fluorescent en face BBI images using an Olympus BX41 microscope. The 
BBI stain that was used Hoechst 33258 pentahydrate by Invitrogen. 
 
Components 
 
• 10 µL BBI stock solution 
• 10 mL milli-Q water 
• Forceps 
• Foil 
• 15-mL conicals for each sample 
 
Protocol 
 
1. Wrap nonsterile 15-mL conicals in foil. Thoroughly label conicals for all samples. 
2. Make BBI solution. Always keep stock solution wrapped in foil! 
a. Use small tube of stock solution and dilute 1:1000 with milli-Q water (10 µL 
stock solution in 10 mL water). Use pipette aid from room 209 hood for milli-Q 
water; spray pipette aid before placing back in hood. 
b. Mix by inverting. 
3. Put on safety glasses. Cut samples with blade or scissors, being careful to not disrupt 
cell lining inside lumen (squeezing, touching, and scraping can all disrupt lining and 
ruin experiment). 
4. Use washed forceps to place samples in corresponding 15-mL conicals that contain 
BBI solution. Carefully keep track of samples. Leave foil on conicals. 
a. Let samples soak for at least 15 minutes (longer is better). 
5. Put away extra stock solution. Clean up preparation area. 
6. With permission or help from Dr. Cardinal, use fluorescent microscope to obtain en 
face images. Take forceps to use at microscope. See figure G.1 for pictures of steps 
below. 
a. Log into notebook (fluorescence; initials; date; time and lamp hours). 
b. Turn turret to setting 4. 
c. Turn on Olympus lamp (green switch). 
d. Turn on Optiscan wheels (black switch). 
e. Turn on camera (black switch). 
f. Set filter wheel 1 to 1, and set filter wheel 2 to 1. 
g. Open shutter: 
h. Set Prior keypad to shutter S1. 
i. Dial objectives to desired magnification (typically 4x and 10x for BBI images). 
j. Set thin bar to icon of eye and camera. 
k. Sign into computer by clicking Dr. Cardinal’s account (password can be obtained 
from Dr. Cardinal). 
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l. Click QCapture Pro (on desktop). 
m. Click camera icon at top of QCapture Pro window:  
n. Place slide on microscope. Place sample on slide. 
o. See figure G.2. 
p. Manually adjust microscope to clarify image. 
q. If scaffold is too wet, carefully blot end of scaffold on Kim wipe. 
r. Take pictures. Save pictures if desired (labeled with sample info, initials, and 
magnification). 
s. Quit QCapture Pro. Log out of computer. 
t. Shut down microscope by switching off Olympus lamp, switching off Optiscan 
wheels, switching off camera (on top of microscope), and closing shutter. 
u. Log out of notebook. 
 
 
 
 
Figure G.1. Microscope anatomy. Letters correspond to step 6 in the protocol. 
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Figure G.2. QCapture Pro control panel. 
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Appendix H: Protocol for Developing HUVEC-Sodded Complex-Shaped BVMs 
 
Purpose 
 
The following protocol was used to tissue-engineer HUVEC-only S-, L-, and U-shaped 
BVMs. This protocol has not been used to tissue-engineer bifurcated BVMs. 
 
Components 
 
• ePTFE scaffold(s) 
• 1.5 million HUVECs/cm2 of scaffold 
• Conditioning media (See Appendix E) 
• Bioreactor media (See Appendix D) 
• HUVEC media (See Appendix C) 
• Sterile 70% EtOH and sterile 100% EtOH 
• Silk Suture 
• Forceps 
• Degassing flask with rubber stopper 
• Multifunctional bioreactor (including 3 luer plugs and 2 rotating male-to-male luer 
lock connectors) 
• Peristaltic pump 
• Sterile gloves 
 
Protocol 
 
Preparation (Approximately 1.5 weeks prior to “Setup”) 
1. Wash all multifunctional bioreactors, bioreactor lids, and two-port lids with water, 
and dry overnight. 
2. Sterilize multifunctional bioreactors, bioreactor lids, and two-port lids by placing 
them in individual sterilization bags and taking them to the Cal Poly Vet Clinic for 
EtO gassing. 
3. Thaw, plan out calendar of cell culture, and begin cell culture. 
4. Cut ePTFE scaffolds to the dimensions described in Section 2.3.2, and wear gloves 
while doing so. 
 
Preparation (Approximately 1 day prior to “Setup”) 
5. Sterilize ePTFE scaffolds, forceps, and degassing flask 
6. Make media (listed in components list above). 
7. Degass conditioning media 
8. Denucleate scaffolds by placing first placing them in 70% EtOH for 10 minutes and 
then 100% EtOH for 10 minutes. 
9. Protein-coat scaffolds by placing them in the degassed conditioning media overnight 
in the small incubator at 37˚C. 
 
“Setup” Day 
10. Warm up bioreactor media, conditioning media, and HUVEC media in water bath. 
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11. Fill biochamber with bioreactor media. 
12. Insert sterile graft into biochamber using sterile gloves. 
13. Number biochamber lids with tape and marker. 
14. Using syringe, flush lumen with conditioning media to prime scaffold. 
15. Clamp lumen and continue to prime scaffold. 
16. Repeat for all scaffolds. 
17. Prime 2-port reservoirs with conditioning media. 
18. Attach primed biochamber to 2-port reservoir and condition scaffold for 10 minutes. 
Administer flow through lumen first to remove air, then clamp lumen and condition 
transmurally on 150-rpm setting. 
19. Leave primed biochambers in large incubator until ready for sodding step. 
20. Prime 2-port reservoirs with HUVEC. Prepare a reservoir for each vessel. Be sure 
that drip is visible and outlet is submerged. Clamp tubing and leave in big incubator. 
21. Take primed biochambers and reservoirs to hood. 
22. Attach outlet of reservoir to inlet stopcock of biochamber. 
23. Leave reservoir inlet unattached and biochamber outlet facing trough. 
24. Harvest HUVECs from T225: apply trypsin; deactivate with HUVEC media. 
25. Pellet cell suspension (on centrifuge setting 4 for 4 minutes). 
26. Resuspend pellet in 4 mL HUVEC media. 
27. Prepare one trough of 10 mL HUVEC media and one trough of 4 mL cell suspension. 
28. Prime tubing by capping off proximal stopcock so fluid will flow back into reservoir. 
Inject 5 mL HUVEC media. Immediately replace stopcock to 45-degree angle. 
Detach syringe. 
29. Sod cells. 
a. Take up 4 mL cell solution in syringe. 
b. Slightly twist stopcock so fluid bulges out of tip of stopcock. 
c. Attach syringe to stopcock. 
d. Toggle stopcock to allow fluid to flow only distally through graft. 
e. Inject 4 mL cell solution. 
f. While still pressuring syringe, cap off stopcock to 45-degree angle. Detach 
syringe. 
30. Chase cells by repeating step 29 with 4 mL HUVEC media instead of 4 mL cell 
solution. 
31. Replace old reservoir with new HUVEC media reservoir. Tighten reservoir cap. 
32. Move complex-shaped BVM system to large incubator. 
33. Maintain transmural flow at 10 rpm for 30 minutes. 
34. Stop transmural flow, and maintain luminal flow at 15 rpm for 24 hours. 
35. Repeat steps 22 through 34 for each bioreactor. 
 
Day After “Setup Day” 
36. Take down 1-day BVMs (Appendix F). 
37. Perform desired adjustment of flow rate depending on the experiment being 
performed. 
38. Take down BVMs at correct time points. 
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Appendix I: Raw Data for Cell Deposition Study 
 
Purpose 
 
This appendix includes BBI images from each region along the length of the 6 complex-
shaped BVMs of Chapter 3 (Figures I.1–I.6), raw cell counts for L- and U-shaped BVMs 
(Tables I.1–I.2 respectively), and a description of the method used to convert raw cell 
counts to cell densities with units of cells/cm2. 
 
Figures 
 
 
 
Figure I.1. L-Shaped BVM 1. A BBI image is shown for each segment along the length 
of the BVM: Proximal 1 (A), Proximal 2 (B), Middle (C), Distal 1 (D), and Distal 2 (E). 
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Figure I.2. L-Shaped BVM 2. A BBI image is shown for each segment along the length 
of the BVM: Proximal 1 (A), Proximal 2 (B), Middle (C), Distal 1 (D), and Distal 2 (E). 
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Figure I.3. L-Shaped BVM 3. A BBI image is shown for each segment along the length 
of the BVM: Proximal 1 (A), Proximal 2 (B), Middle (C), Distal 1 (D), and Distal 2 (E). 
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Figure I.4. U-Shaped BVM 1. A BBI image is shown for each segment along the length 
of the BVM: Proximal 1 (A), Proximal 2 (B), Middle (C), Distal 1 (D), and Distal 2 (E). 
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Figure I.5. U-Shaped BVM 2. A BBI image is shown for each segment along the length 
of the BVM: Proximal 1 (A), Proximal 2 (B), Middle (C), Distal 1 (D), and Distal 2 (E). 
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Figure I.6. U-Shaped BVM 3. A BBI image is shown for each segment along the length 
of the BVM: Proximal 1 (A), Proximal 2 (B), Middle (C), Distal 1 (D), and Distal 2 (E). 
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Tables 
 
Table I.1. Raw Cell Counts for 3 L-Shaped BVMs 
 
BVM Distal 2 Distal 1 Middle Proximal 2 Proximal 1 
1: Inner  
Top 30 28 30 30 30 28 29 35 31 30 
Bottom 29 30 33 32 29 27 29 26 30 30 
1: Outer 
Top 32 31 30 31 32 30 31 30 28 29 
Bottom 37 35 32 33 32 30 29 32 30 28 
2: Inner 
Top 34 30 32 32 33 31 31 31 29 29 
Bottom 31 31 32 31 33 31 31 31 29 31 
2: Outer 
Top 29 32 31 35 34 34 33 33 32 30 
Bottom 28 29 35 31 33 37 33 34 30 33 
3: Inner 
Top 29 32 33 36 35 37 33 31 30 29 
Bottom 27 33 32 32 36 36 33 32 30 28 
3: Outer 
Top 27 31 33 33 36 36 34 35 28 33 
Bottom 28 31 40 36 35 39 35 33 33 34 
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Table I.2. Raw Cell Counts for 3 U-Shaped BVMs 
 
BVM Distal 2 Distal 1 Middle Proximal 2 Proximal 1 
1: Inner 
Top 31 32 34 30 24 24 25 30 29 26 
Bottom 31 35 35 24 32 27 30 33 22 24 
1: Outer (Cells were not counted in the outer half of U-shaped BVM 1) 
Top           
Bottom           
2: Inner 
Top 25 22 22 23 28 27 24 28 25 27 
Bottom 23 22 27 31 31 31 30 31 32 27 
2: Outer 
Top 30 29 30 35 32 31 29 28 21 23 
Bottom 26 29 30 28 27 31 27 26 19 20 
3: Inner 
Top 25 24 29 29 30 28 32 26 23 26 
Bottom 26 28 28 27 29 30 28 26 27 23 
3: Outer 
Top 29 25 32 34 30 35 32 32 37 33 
Bottom 23 28 31 32 33 29 28 31 29 29 
 
 
Method for Converting Cell Counts to Cell Densities 
 
Each side of the small white boxes in Figure 3.7 is 100 µm, therefore each small white 
box has an area of 10,000 µm2. To convert cell counts to cell densities, the average cell 
count for each image was divided by the area of one small white box and then multiplied 
by the following: 
 
! 
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Appendix J: Minitab Output for Cell Deposition Study 
 
Purpose 
 
This appendix contains the Minitab output that was generated for the statistical analyses 
of L- and U-shaped BVMs in Chapter 3 (Figures J.1–J.2). 
 
Minitab Output 
 
 
 
 
 
Figure J.1. Minitab output for cell density comparisons throughout L-shaped BVMs. p-
values are written in red. A statistically significant difference existed between cell 
densities in the 5 regions along the length of L-shaped BVMs (p = 0.000), between the 
cell densities in the inner and outer halves of L-shaped BVMs (p = 0.011), but not 
between the cell densities in the top and bottom halves of L-shaped BVMs (p = 0.607). 
Kruskal-Wallis Test: Density versus Top/Bottom  
 
Kruskal-Wallis Test on Density 
 
Top/Bottom    N  Median  Ave Rank      Z 
Bottom       60  320000      62.1   0.51 
Top          60  310000      58.9  -0.51 
Overall     120              60.5 
 
H = 0.26  DF = 1  P = 0.607 
H = 0.27  DF = 1  P = 0.604  (adjusted for ties) 
 
Kruskal-Wallis Test: Density versus Inner/Outer  
 
Kruskal-Wallis Test on Density 
 
Inner/Outer    N  Median  Ave Rank      Z 
Inner         60  310000      52.5  -2.53 
Outer         60  320000      68.5   2.53 
Overall      120              60.5 
 
H = 6.39  DF = 1  P = 0.011 
H = 6.48  DF = 1  P = 0.011  (adjusted for ties) 
Kruskal-Wallis Test: Density versus Region  
 
Kruskal-Wallis Test on Density 
 
Region        N  Median  Ave Rank      Z 
Distal 2     24  305000      45.6  -2.35 
Distal 1     24  320000      74.8   2.24 
Middle       24  330000      77.1   2.61 
Proximal 2   24  320000      66.0   0.86 
Proximal 1   24  300000      39.1  -3.37 
Overall     120              60.5 
 
H = 23.58  DF = 4  P = 0.000 
H = 23.93  DF = 4  P = 0.000  (adjusted for ties) 
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Figure J.2. Minitab output for cell density comparisons throughout U-shaped BVMs. p-
values are written in red. A statistically significant difference existed between cell 
densities in the 5 regions along the length of L-shaped BVMs (p = 0.008) but not between 
the cell densities in the inner and outer halves of L-shaped BVMs (p = 0.057) nor 
between the cell densities in the top and bottom halves of L-shaped BVMs (p = 0.810). 
One-way ANOVA: Density versus Top/Bottom  
 
Source      DF           SS          MS     F      P 
Top/Bottom   1     81000000    81000000  0.06  0.810 
Error       98  1.36978E+11  1397734694 
Total       99  1.37059E+11 
 
S = 37386   R-Sq = 0.06%   R-Sq(adj) = 0.00% 
 
One-way ANOVA: Density versus Inner/Outer  
 
Source       DF           SS          MS     F      P 
Inner/Outer   1   4988166667  4988166667  3.70  0.057 
Error        98  1.32071E+11  1347661565 
Total        99  1.37059E+11 
 
S = 36711   R-Sq = 3.64%   R-Sq(adj) = 2.66% 
 
One-way ANOVA: Density versus Region  
 
Source  DF           SS          MS     F      P 
Region   4  18514000000  4628500000  3.71  0.008 
Error   95  1.18545E+11  1247842105 
Total   99  1.37059E+11 
 
S = 35325   R-Sq = 13.51%   R-Sq(adj) = 9.87% 
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Appendix K: SEM Imaging Protocol 
 
Purpose 
 
The following protocol was followed when carrying out any SEM imaging throughout 
the research described in this thesis. 
 
Components 
 
• 100% Ethanol 
• Distilled water 
• Miniature glass jars 
• Forceps 
• Pipet-Aid 
• Pipettes 
 
Protocol 
 
1. Prepare the following solutions of ethanol by diluting 100% ethanol with water: 25% 
ethanol, 50% ethanol, 70% ethanol, 90% ethanol. 
2. Allot one miniature glass jar for each dilution, and place the dilutions in their 
respective jars. Prepare two jars for 100% ethanol. 
3. Place 2 mL of each dilution into its respective jar. 
4. Dehydrate BVM samples by placing samples in each diltuion for 5 minutes starting 
with 25% ethanol. Be careful not to disrupt samples or tip of miniature glass jars. 
5. Place samples in dessicator overnight. 
6. Image samples using Hitachi TM-1000 SEM. 
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Appendix L: Histology and White Light Imaging Protocol 
 
Purpose 
 
The following protocol was followed when carrying out histology and white light 
imaging of histology samples throughout the research described in this thesis. 
 
Components 
 
Histology reagents 
Olympus BX41 microscope 
 
Protocol 
 
After embedding samples in paraffin, sectioning samples, and placing samples in oven, 
run samples through the following reagents for the specified times. 
 
1. 3 min – xylene 1 
2. 3 min – xylene 2 
3. 1 min – Air 
4. 2 min – 100% 
5. 2 min – 100% 
6. 2 min – 95% 
7. 2 min – Air 
8. 4 min – Hematoxylin 
9. 1 min – H2O (distilled) 
10. 30 sec – Clarifier 
11. 1 min – Bluing 
12. 1 min – 95% 
13. 1 min 30 sec – Eosin 
14. 1 min – 100% 
15. 1 min – Air 
16. 1 min – xylene 1 
17. 1 min – xylene 2 
 
Mount samples on slides, place coverslips on slides, and allow slides to dry for 2 days. 
 
With permission or help from Dr. Cardinal, use the white-light microscope to obtain 
images of samples mounted on slides. The following steps detail operation of the white-
light microscope and correspond to figure L.1. 
 
1. Log into notebook (white; initials; date; time and lamp hours). 
2. Turn turret to setting 1. 
3. Turn on Optiscan wheels (black switch). 
4. Turn on camera (black switch). 
5. Set filter wheel 2 to 5. 
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6. Open shutter: 
7. Set Prior keypad to shutter S1. 
8. Turn on white light (black switch on side of microscope arm). 
9. Dial objectives to desired magnification (typically 10x for histology images of cell-
sodded scaffolds). 
10. Set thin bar to icon of eye and camera. 
11. Sign into computer by clicking Dr. Cardinal’s account (password can be obtained 
from Dr. Cardinal). 
12. Click QCapture Pro (on desktop). 
13. Click camera icon at top of QCapture Pro window:  
14. Place slide on microscope. Use joystick to move sample under microscope lens. 
15. See figures L.2 and L.3. 
16. Use dial on base of microscope to adjust exposure of live image. 
17. Use course focus and fine focus on base of microscope to clarify live image. 
18. See figure L.4. 
19. Refocus live image if desired. Click Snap to take pictures. Save pictures if desired 
(labeled with sample info and magnification). 
20. Quit QCapture Pro. Log out of computer. 
21. Shut down microscope by switching off Optiscan wheels, camera (on top of 
microscope), and white light (on side of microscope arm). 
22. Log out of notebook. 
 
 
 
Figure L.1. Microscope anatomy. Numbers in figure correspond to steps above. 
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Figure L.2. QCapture Pro home window and control panel. 
 
 
 
Figure L.3. QCapture Pro displays live image of sample. 
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Figure L.4. QCapture Pro adjusts lighting of live image. 
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Appendix M: HUVSMC Media Preparation 
 
Purpose 
 
The following was the list of components used to make HUVSMC media and the 
protocol that was followed to make this media. This protocol utilized SmGM®-2 
SingleQuots® (Lonza). 
 
Components 
 
• 500 mL Smooth muscle cell medium 
• Other packaged components 
 
Protocol 
 
1. In a laminar flow hood, attach filter to bottle. 
2. Attach vacuum to filter. Turn on vacuum. 
3. Pour approximately 400 mL of smooth muscle cell medium into filter, leaving the 
remaining 100 mL to wash down other components from sides of filter. 
4. Add the remaining components into the filter, using a pipette to acquire the exact 
quantities of each component. 
5. Wash the filter with the remaining 100 mL of smooth muscle cell medium. 
6. Detach the filter from the bottle. Cap the bottle. Place tape label on bottle that 
includes “HUVSMC Media,” date, and initials. 
7. Place labeled bottle in refrigerator (4˚C). 
8. Before using media from refrigerator, warm media to 37˚C in water bath. 
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Appendix N: Cell Tracker™ Preparation 
 
Purpose 
 
This appendix includes the components and protocol used to prepare the Cell Tracker™ 
solutions that were used during the tissue-engineering of dual-sodded U-shaped BVMs in 
Chapter 6. 
 
Components 
 
• 5-20 µL pipette and sterile head 
• 3-mL syringe with needle tip 
• DMSO 100-mL bottle (anhydrous, Sigma-Aldrich, catalog number 276855) 
• Cell Tracker™ Red (Invitrogen, Carlsbad, CA, catalog number C34522) 
• Cell Tracker™ Green (Invitrogen, Carlsbad, CA catalog number C7025) 
• Sterile serum-free media 
• Pipettes 
 
Protocol 
 
1. Warm media in water bath. 
2. Use needle tip and syringe to pull out 1 mL of DMSO, and place in 15-mL conical. 
3. Use micropipette to pull out 10.8µL of DMSO from 15-mL conical. 
4. Add DMSO to vial of Cell Tracker™. Attempt to get most of powdered Cell 
Tracker™ in with DMSO. This is a 10-mM concentration of stock solution. 
5. Dilute stock solution to desired concentration to create working solution. Use 
equation c1v1 = c2v2, where c1 = 10 mM (from stock solution), v1 = unknown, c2 = 
desired concentration, and v2 = final volume needed. 
6. Vortex working solution for use. Working solution can be stored in fridge for up to 
one week. 
7. Remove cell media from flasks of cells. 
8. Add working solution to flasks of cells. 
9. Incubate flasks containing Cell Tracker™ Green for 30 minutes and flasks containing 
Cell Tracker™ Red for 15 minutes. 
10. Remove working solution from flasks of cells. 
11. Add cell media back into flasks of cells. 
12. Incubate flasks for at least 30 minutes. 
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Appendix O: Protocol for Developing Dual-Sodded Complex-Shaped BVMs 
 
Purpose 
 
The following protocol was used to tissue-engineer dual-sodded U-shaped BVMs. This 
protocol has not been used to tissue-engineer any other complex-shaped BVM. 
 
Components 
 
• ePTFE scaffold(s) 
• 1.5 million HUVSMCs/cm2 of scaffold 
• 1.5 million HUVECs/cm2 of scaffold 
• Conditioning media (See Appendix E) 
• Bioreactor media (See Appendix D) 
• HUVEC media (See Appendix C) 
• HUVSMC media (See Appendix M) 
• Cell Tracker™ 
• Sterile 70% EtOH and sterile 100% EtOH 
• Silk Suture 
• Forceps 
• Degassing flask with rubber stopper 
• Multifunctional bioreactor (including 3 luer plugs and 2 rotating male-to-male luer 
lock connectors) 
• Peristaltic pump 
• Sterile gloves 
 
Protocol 
 
Preparation (Approximately 1.5 weeks prior to “Setup”) 
1. Wash all multifunctional bioreactors, bioreactor lids, and two-port lids with water, 
and dry overnight. 
2. Sterilize multifunctional bioreactors, bioreactor lids, and two-port lids by placing 
them in individual sterilization bags and taking them to the Cal Poly Vet Clinic for 
EtO gassing. 
3. Thaw, plan out calendar of cell culture, and begin cell culture. 
4. Cut ePTFE scaffolds to the dimensions described in Section 2.3.2, and wear gloves 
while doing so. 
 
Preparation (Approximately 1 day prior to “Setup”) 
5. Sterilize ePTFE scaffolds, forceps, and degassing flask 
6. Make media (listed in components list above). 
7. Degass conditioning media 
8. Denucleate scaffolds by first placing them in 70% EtOH for 10 minutes and then 
100% EtOH for 10 minutes. 
9. Protein-coat scaffolds by placing them in the degassed conditioning media overnight 
in the small incubator at 37˚C. 
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“Setup” Day 
10. Warm up bioreactor media, conditioning media, HUVEC media, HUVSMC media. 
11. Prepare Cell Tracker™ Green and Red solutions. 
12. Fill biochamber with bioreactor media. 
13. Insert sterile graft into biochamber. 
14. Number biochamber lids with tape and marker. 
15. Using syringe, flush lumen with conditioning media to prime graft. 
a. Clamp lumen and continue to prime graft. 
b. Repeat for all grafts. 
16. Prime 2-port reservoirs with conditioning media. 
17. Attach primed biochamber to 2-port reservoir and condition graft for 10 minutes. 
a. Flow through lumen first to remove air, then clamp lumen and condition 
transmurally on 150-rpm setting. 
18. Leave primed biochambers in large incubator until ready for sodding step. 
19. Prime 2-port reservoirs with 75% HUVEC media and 25% HUVSMC media. 
a. Prepare one for each vessel. 
b. Be sure that drip is visible and outlet is submerged. 
c. Clamp tubing and leave in big incubator. 
20. Take primed biochambers and reservoirs to hood. 
21. Attach outlet of reservoir to inlet stopcock of biochamber. 
a. Leave reservoir inlet unattached and biochamber outlet facing trough. 
22. Place 9 mL of Cell Tracker™ Green solution in 15 mL conical. 
23. Vortex solution. 
24. Remove HUVSMC media from T225 of HUVSMCs. 
25. Add 9 mL of Cell Tracker™ Green solution to T225 of HUVSMCs (to cover total 
surface area of T225). 
26. Place T225 in incubator for 30 minutes. 
27. Remove Cell Tracker™ Green solution from T225. 
28. Add 9 mL HUVSMC media to T225 (to keep cells alive before sodding). 
29. Incubate T225 for 30 minutes. 
30. Harvest HUVSMCs from T225. 
a. Apply trypsin; deactivate with HUVSMC media. 
31. Pellet cell suspension (on 4 for 4 minutes). 
32. Resuspend pellet in 4 mL HUVSMC media. 
33. Prepare one trough of 10 mL HUVSMC media and one trough of 4 mL cell 
suspension. 
34. Prime tubing by capping off proximal stopcock so fluid will flow back into reservoir. 
Inject 5 mL HUVSMC media. Immediately replace stopcock to 45-degree angle. 
Detach syringe. 
35. Sod cells. 
a. Take up 4 mL cell solution in syringe. 
b. Slightly twist stopcock so fluid bulges out of tip of stopcock. 
c. Attach syringe to stopcock. 
d. Toggle stopcock to allow fluid to flow only distally through graft. 
e. Inject 4 mL cell solution. 
 187 
f. While still pressuring syringe, cap off stopcock to 45-degree angle. Detach 
syringe. 
36. Chase cells by repeating step 35 with 4 mL HUVSMC media instead of 4 mL cell 
solution. 
37. Move BVM system to large incubator. 
38. Maintain transmural flow at 10 rpm for 30 minutes. 
39. Repeat steps 22 through 39 for each bioreactor. 
40. Place 9 mL of Cell Tracker™ Red solution in 15 mL conical. 
41. Vortex solution. 
42. Remove HUVEC media from T225 of HUVECs. 
43. Add 9 mL of Cell Tracker™ Red solution to T225 of HUVECs (to cover total surface 
area of T225). 
44. Place T225 in incubator for 15 minutes. 
45. Remove Cell Tracker™ Red solution from T225. 
46. Add 9 mL HUVEC media to T225 (to keep cells alive before sodding). 
47. Incubate T225 for 30 minutes. 
48. Harvest HUVECs from a T225. 
a. Apply Trypsin; deactivate with HUVEC media. 
49. Pellet cell suspension (on 4 for 4 minutes). 
50. Resuspend pellet in 4 mL HUVEC media. 
51. Prepare one trough of 10 mL HUVEC media and one trough of 4 mL cell suspension. 
52. Prime tubing by capping off proximal stopcock so fluid will flow back into reservoir. 
Inject 5 mL HUVEC media. Immediately replace stopcock to 45-degree angle. 
Detach syringe. 
53. Sod cells. 
a. Take up 4 mL cell solution in syringe. 
b. Slightly twist stopcock so fluid bulges out of tip of stopcock. 
c. Attach syringe to stopcock. 
d. Toggle stopcock to allow fluid to flow only distally through graft. 
e. Inject 4 mL cell solution. 
f. While still pressuring syringe, cap off stopcock to 45-degree angle. Detach 
syringe. 
54. Chase cells by repeating step 43 with 4 mL HUVEC media instead of 4 mL cell 
solution. 
55. Move BVM system to large incubator. 
56. Maintain transmural flow at 10 rpm for 30 minutes. 
57. Stop transmural flow, and maintain luminal flow at 10 rpm for 1 hour. 
58. Increase luminal flow to 15 rpm, and maintain for 1 hour. 
59. Increase luminal flow to 20 rpm, and maintain overnight. 
60. Take down 1-day BVMs. 
61. Increase flow by 15 rpm every hour to reach 150 rpm. 
62. Take down 4-day BVMs. 
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Appendix P: Copyright Reprint Permissions 
 
Figure 1.1 A and B Reprint Permissions 
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Figure 1.2 A Reprint Permissions 
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